← 產業報告目錄

Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Biopharma) - Global Forecast to 2030

出版商 MarketsandMarkets產業別 Healthcare & Life Sciences出版日期 2026-01-27頁數 983報告編號 BT2341

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The global proteomics market is projected to reach USD 65.78 billion by 2030 from USD 36.32 billion in 2025, at a CAGR of 12.6% from 2025 to 2030. Rising use of proteomics in oncology, immunology and other complex diseases is pushing higher routine demand for protein profiling across global labs. Pharma and biotech teams are expanding biomarker programs and running larger translational cohorts, which increases throughput needs for LC-MS workflows, targeted panels, and standardized sample preparation. “The immunoassay reagents segment accounted for the largest share by reagent in the proteomics market in 2024” Based on reagent, the proteomics market is segmented into, protein microarray reagents, spectroscopy reagents, X-ray crystallography reagents, chromatography reagents, electrophoresis reagents, immunoassay reagents, and protein fractionation reagents. The immunoassay reagents dominated the reagent segment; however spectroscopy reagent is anticipated to grow at significant CAGR during the forecast period. Factors like growing use of mass spectrometry-based techniques, development of high-throughput mass spectrometry techniques, increasing interest in personalized medicine and biomarker discovery are likely to drive the segmental growth.   “The biopharmaceutical companies segment accounted for the largest share by end user segment in the proteomics market in 2024” Based on end user, the proteomics market is segmented into hospitals, clinical laboratories, biopharmaceutical companies, academic & research institutes, and other end users. The biopharmaceutical companies segment dominated the proteomics market owing to the rising focus of pharma giants on core activities like increasing R&D for the discovery and development of new molecules. “The Asia Pacific region is growing at the highest CAGR in the proteomics market from 2025 to 2030.” Geographically, the proteomics market is segmented into North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. In 2023, North America accounted for the major share of the proteomics market. The Asia Pacific region is likely to grow at significant CAGR during the forecast period owing to various factors such as growing fields of proteomics and genomics research in conjunction with an increase in funding toward research studies. Rising investment by biopharmaceutical companies, growing research activity in the area of mAb-based therapeutics are likely to drive market expansion in the region. The primary interviews conducted for this report can be categorized as follows: • By Company Type: Tier 1- 40%, Tier 2- 30% and Tier 3- 30% • By Designation: Directors- 20%, Managers- 10% and Others - 70%, • By Region: North America -35%, Europe -25%, Asia-Pacific -25%, Latin America -10%, and Middle East -5%. List of Companies Profiled in the Report: • Thermo fisher Scientific Inc (US) • Agilent Technologies, Inc. (US) • Merck KGaA (Germany) • Danaher Corporation (US) • Waters Corporation (US) • Bio-Rad Laboratories, Inc. (US) • Bruker Corporation (US) • Revvity (US) • Shimadzu Corporation (Japan) • Illumina Inc (US) • Promega Corporation (US) • Eurofins Scientific (Luxembourg) • Qiagen (Netherlands) • Charles River Laboratories (US) • Protagene (Germany) • Creative Proteomics (US) • Horiba (Japan) • Sengenics Corporation LLC (US) • Labvantage-Biomax GmbH (Germany) • Cell Signaling Technology, Inc. (US) • FIOS Genomics (UK) • Azenta Life Sciences (US) • Medgenome (India) • Biognosys AG (Switzerland) • Macrogen Inc (South Korea) Research Coverage: This research report categorizes the proteomics market by Instrumentation Technology : Spectroscopy (Mass spectroscopy, NMR spectroscopy, CD spectroscopy), Chromatography (High performance liquid chromatography, Ion chromatography, Affininty chromatography, Supercritical fluid chromatography), Electrophoresis (Gel electrophoresis, Capillary electrophoresis), Protein Microarrays (Biochips, Microarray instruments), X ray Crystallography, Surface Plasmon Resonance , Protein fractionation, Other intrumentation technologies; by reagent: Immunoassay reagents, spectroscopy reagents, chromatography reagents, protein microarray reagents, X‑ray crystallography reagents, electrophoresis reagents, protein fractionation reagents, other reagents; by Service: Core proteomics services (Protein indentification services, Quantitative proteomics services, Protein characterization services, Protein purification services, Protein separation services, Protein sequencing services, Custom assay services), Bioinformatics services; by software: Bioinformatics Tools, Bioinformatics databases; by Application: Clinical Diagnostics (Cancer, Infectious diseases, Diabetes, Neurological disorders, Autoimmune diseases, Cardiovascular diseases, Other clinical diagnostic applications), Drug discovery & Development (Target discovery, Lead identification, Lead optimization, Preclinical studies), Other applications; by End User: Biopharmaceutical Companies, Academic Institutes & Research Institutes, Hospitals, Clinical laboratories, Other end users and by region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa). The scope of the report covers detailed information regarding the major factors, such as drivers, challenges, opportunities, and restraints, influencing the growth of the proteomics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, product portfolio, key strategies such as product launches, collaborations, partnerships, expansions, agreements, and recent developments associated with the proteomics market. Competitive analysis of top players and upcoming startups in the proteomics market ecosystem is covered in this report. Key Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall proteomics market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges. The report provides insights on the following pointers: Analysis of key drivers (Strong pull from oncology and proteogenomics programs, Growth in multi-omics), restraints (High total cost of ownership), opportunities (Single-cell and low-input proteomics, Cloud and shared data platforms to accelerate discovery), and challenges (Data volume, interpretation and bioinformatics bottlenecks) influencing the growth of the market. • Product Development/Innovation: Detailed insights on newly launched products and services of the proteomics market • Market Development: Comprehensive information about lucrative markets - the report analyses the market across varied regions. • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the proteomics market • Competitive Assessment: Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Bio‑Rad Laboratories (US), Revvity (US), Illumina Inc. (US), Promega Corporation (US) and Charles River Laboratories (US), among others.
目錄 Table of Contents
1 INTRODUCTION 78 1.1 STUDY OBJECTIVES 78 1.2 MARKET DEFINITION 78 1.3 STUDY SCOPE 78 1.3.1 MARKET SEGMENTATION AND REGIONS COVERED 79 1.3.2 INCLUSIONS & EXCLUSIONS 80 1.3.3 YEARS CONSIDERED 81 1.3.4 CURRENCY CONSIDERED 81 1.4 STAKEHOLDERS 82 1.5 SUMMARY OF CHANGES 82 2 EXECUTIVE SUMMARY 83 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS 83 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS 84 2.3 DISRUPTIVE TRENDS IN PROTEOMICS MARKET 85 2.4 HIGH-GROWTH SEGMENTS 86 2.5 REGIONAL SNAPSHOT: MARKET SIZE, GROWTH RATE, AND FORECAST 87 3 PREMIUM INSIGHTS 88 3.1 PROTEOMICS MARKET OVERVIEW 88 3.2 NORTH AMERICA: PROTEOMICS MARKET, BY SERVICE 89 3.3 PROTEOMICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 89 3.4 PROTEOMICS MARKET SHARE, BY APPLICATION, 2026 VS 2031 (%) 90 4 MARKET OVERVIEW 91 4.1 INTRODUCTION 91 4.2 MARKET DYNAMICS 92 4.2.1 DRIVERS 93 4.2.1.1 Advancements in DIA and high-throughput mass spectrometry 93 4.2.1.2 Growing clinical and plasma proteomics adoption for biomarker discovery and translational diagnostics 93 4.2.1.3 Rising integration of proteomics with multi-omics workflows 94 4.2.1.4 Expansion of automation and low-input proteomics workflows 94 4.2.2 RESTRAINTS 94 4.2.2.1 High capital intensity of high-resolution mass spectrometry platforms 94 4.2.2.2 Complexity of proteomics data analysis 95 4.2.3 OPPORTUNITIES 95 4.2.3.1 Emergence of single-cell proteomics for high-resolution cellular profiling 95 4.2.3.2 Expansion of spatial proteomics in tissue-context biology and biomarker research 95 4.2.3.3 Adoption of AI-enabled proteomics informatics 96 4.2.4 CHALLENGES 96 4.2.4.1 Limited detection of low-abundance proteins 96 4.2.4.2 Lack of standardization across workflows 97 4.3 UNMET NEEDS AND WHITE SPACES 97 4.4 INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES 98 4.5 STRATEGIC MOVIES BY TIER-1/2/3 PLAYERS 99 5 INDUSTRY TRENDS 100 5.1 PORTER’S FIVE FORCES ANALYSIS 100 5.1.1 INTENSITY OF COMPETITIVE RIVALRY 101 5.1.2 BARGAINING POWER OF SUPPLIERS 101 5.1.3 BARGAINING POWER OF BUYERS 101 5.1.4 THREAT OF SUBSTITUTES 101 5.1.5 THREAT OF NEW ENTRANTS 101 5.2 MACROECONOMIC OUTLOOK 102 5.2.1 INTRODUCTION 102 5.2.2 GDP TRENDS AND FORECAST 102 5.2.3 TRENDS IN GLOBAL HEALTHCARE INDUSTRY 102 5.2.4 TRENDS IN GLOBAL BIOTECH INDUSTRY 103 5.3 VALUE CHAIN ANALYSIS 104 5.4 ECOSYSTEM ANALYSIS 105 5.4.1 ROLE OF PLAYERS IN ECOSYSTEM 106 5.5 PRICING ANALYSIS 107 5.5.1 AVERAGE SELLING PRICE TREND, KEY PLAYER, 2023-2025 108 5.5.1.1 Instrumentation 108 5.5.1.2 Reagents 109 5.5.2 AVERAGE SELLING PRICE TREND, BY REGION, 2023–2025 109 5.5.2.1 Instrumentation 109 5.5.3 REAGENTS 110 5.6 TRADE ANALYSIS 111 5.6.1 IMPORT SCENARIO (HS CODE 9027.20) 111 5.6.2 EXPORT SCENARIO (HS CODE 9027.20) 112 5.6.3 IMPORT SCENARIO (HS CODE 9027.81) 112 5.6.4 EXPORT SCENARIO (HS CODE 9027.81) 113 5.7 KEY CONFERENCES & EVENTS, 2026–2027 114 5.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 114 5.9 INVESTMENT & FUNDING SCENARIO 115   5.10 CASE STUDY ANALYSIS 116 5.10.1 PLASMA PROTEOMICS IMPROVES RISK PREDICTION ACROSS MULTIPLE DISEASES 116 5.10.2 PLASMA PROTEOMICS SUPPORTS ALS BIOMARKER DISCOVERY 116 5.10.3 AI-ENABLED PROTEOMICS ADVANCES DEMENTIA DIAGNOSTICS 117 5.11 IMPACT OF US TARIFF—PROTEOMICS MARKET 117 5.11.1 INTRODUCTION 117 5.11.2 KEY TARIFF RATES 117 5.11.3 PRICE IMPACT ANALYSIS 118 5.11.4 IMPACT ON COUNTRIES/REGIONS 119 5.11.4.1 US 119 5.11.4.2 Europe 119 5.11.4.3 Asia Pacific 120 5.11.5 IMPACT ON END-USE INDUSTRIES 120 5.11.5.1 Hospitals 120 5.11.5.2 Clinical laboratories 120 5.11.5.3 Biopharmaceutical companies 121 5.11.5.4 Academic & research institutes 121 6 SUSTAINABILITY AND REGULATORY LANDSCAPE 122 6.1 REGIONAL REGULATIONS AND COMPLIANCE 122 6.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122 6.1.2 INDUSTRY STANDARDS 125 6.1.2.1 North America 125 6.1.2.2 Europe 125 6.1.2.3 Asia Pacific 126 6.1.2.4 Rest of the world 126 6.2 SUSTAINABILITY INITIATIVES 126 6.3 IMPACT OF REGULATORY POLICIES ON SUSTAINABILITY INITIATIVES 127 6.4 CERTIFICATIONS, LABELING, ECO-STANDARDS 127 7 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACT, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS 129 7.1 KEY TECHNOLOGIES 129 7.1.1 MASS SPECTROMETRY 129 7.1.1.1 Intact/top-down protein analysis 129 7.1.1.2 Chromatography 130 7.1.1.3 Bioinformatics tools 130 7.1.1.4 Protein microarrays 130   7.2 COMPLEMENTARY TECHNOLOGIES 131 7.2.1 TRANSCRIPTOMICS 131 7.2.2 METABOLOMICS 131 7.2.3 SINGLE-CELL PROTEOMICS 131 7.3 ADJACENT TECHNOLOGIES 132 7.3.1 AI-DRIVEN PROTEOMICS DATA ANALYSIS 132 7.3.2 AI-DRIVEN PROTEIN STRUCTURE & FUNCTION PREDICTION 132 7.4 TECHNOLOGY ROADMAP 132 7.5 PATENT ANALYSIS 133 7.5.1 METHODOLOGY 133 7.5.2 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE 133 7.5.3 LIST OF KEY PATENTS 134 7.6 FUTURE APPLICATIONS 135 7.7 IMPACT OF AI/GEN AI ON PROTEOMICS MARKET 136 7.7.1 TOP USE CASES AND MARKET POTENTIAL 137 7.7.2 BEST PRACTICES IN AI-ENABLED PROTEOMICS WORKFLOWS 137 7.7.3 CASE STUDIES OF AI IMPLEMENTATION IN PROTEOMICS MARKET 137 7.7.4 INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS 138 7.7.5 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROTEOMICS MARKET 138 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 140 8.1 DECISION-MAKING PROCESS 140 8.2 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 140 8.2.1 KEY STAKEHOLDERS IN BUYING PROCESS 140 8.2.2 KEY BUYING CRITERIA, BY END USER 141 8.3 ADOPTION BARRIERS & INTERNAL CHALLENGES 142 8.4 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 143 9 PROTEOMICS MARKET, BY OFFERING 144 9.1 INTRODUCTION 145 9.2 INSTRUMENTS 145 9.2.1 HIGH-SENSITIVITY AND AUTOMATED PROTEOMICS INSTRUMENT TO DRIVE MARKET GROWTH 145 9.3 REAGENTS & CONSUMABLES 149 9.3.1 SCALABLE MULTIPLEX ASSAYS AND WORKFLOW-READY CONSUMABLES TO DRIVE MARKET 149 9.4 SOFTWARE 152 9.4.1 AI-ENABLED CLOUD-CONNECTED SOFTWARE TO DRIVE MARKET GROWTH 152 9.5 SERVICES 156 9.5.1 OUTSOURCED EXPERTISE AND SCALABLE LC-MS/MS CAPACITY TO DRIVE MARKET 156   10 PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES 160 10.1 INTRODUCTION 161 10.2 IMMUNOASSAY REAGENTS & CONSUMABLES 161 10.2.1 ANTIBODIES & HIGH-AFFINITY BINDERS 165 10.2.1.1 Validated high-affinity binders to aid market growth 165 10.2.2 ASSAY KITS 169 10.2.2.1 Prevalidated assay kits to accelerate market growth 169 10.2.3 OTHER IMMUNOASSAY REAGENTS & CONSUMABLES 172 10.3 SPECTROSCOPY REAGENTS & CONSUMABLES 176 10.3.1 MASS TAGGING & LABELING KITS 180 10.3.1.1 Multiplexed protein quantification to aid market growth 180 10.3.2 ENZYMES 183 10.3.2.1 Automation-ready digestion enzymes to drive market growth 183 10.3.3 OTHER SPECTROSCOPY REAGENTS & CONSUMABLES 186 10.4 CHROMATOGRAPHY REAGENTS & CONSUMABLES 189 10.4.1 ANALYTICAL COLUMNS 193 10.4.1.1 High-sensitivity microflow and bio-inert columns to support market growth 193 10.4.2 REAGENTS 196 10.4.2.1 High-purity and method-compatible solvents to support market growth 196 10.4.3 OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES 199 10.5 PROTEIN MICROARRAY REAGENTS & CONSUMABLES 202 10.5.1 BIOCHIPS 206 10.5.1.1 Miniaturized, functionalized biochips to drive market growth 206 10.5.1.2 Lab-on-chips 210 10.5.1.2.1 Integrated microfluidic chips to propel market growth 210 10.5.1.3 Protein chips 213 10.5.1.3.1 Functional protein chips are converting biomarker and interaction discovery into scalable multiplex assays to aid market growth 213 10.5.2 DETECTION REAGENTS 217 10.5.2.1 Brighter, lower-background detection chemistries to propel market growth 217 10.6 X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES 220 10.6.1 CRYSTALLIZATION SCREENS 224 10.6.1.1 Automated high-throughput screening to drive market growth 224 10.6.2 OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES 228 10.7 ELECTROPHORESIS REAGENTS & CONSUMABLES 231 10.7.1 ELECTROPHORESIS STAINS & DYES 235 10.7.1.1 High-sensitivity and MS-compatible stains to improve protein visualization 235 10.7.2 OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES 238 10.8 PROTEIN FRACTIONATION REAGENTS & CONSUMABLES 242 10.8.1 PROTEIN FRACTIONATION & ENRICHMENT KITS 245 10.8.1.1 Automated enrichment kits to drive market growth 245 10.8.2 OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES 249 10.9 OTHER REAGENTS & CONSUMABLES 253 11 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY 257 11.1 INTRODUCTION 258 11.2 SPECTROSCOPY 258 11.2.1 MASS SPECTROMETRY 262 11.2.1.1 High specificity and technological advancements to propel segment growth 262 11.2.2 NMR SPECTROSCOPY 266 11.2.2.1 Accurate evaluation of physical, chemical, electronic, and structural information of proteins to aid segment growth 266 11.2.3 CD SPECTROSCOPY 270 11.2.3.1 Non-destructive and non-invasive techniques to examine changes in secondary protein structures 270 11.3 CHROMATOGRAPHY 273 11.3.1 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY 277 11.3.1.1 High resolution, sensitivity, and reproducibility to spur segment growth 277 11.3.2 ION CHROMATOGRAPHY 280 11.3.2.1 High resolving power, simplicity, and controllability to separate and purify proteins 280 11.3.3 AFFINITY CHROMATOGRAPHY 284 11.3.3.1 High specificity for target proteins and easy identification of novel protein interactions to drive segment 284 11.3.4 SUPERCRITICAL FLUID CHROMATOGRAPHY 287 11.3.4.1 Ability to separate complex protein mixtures with high efficiency and speed to fuel segment growth 287 11.4 ELECTROPHORESIS 291 11.4.1 GEL ELECTROPHORESIS 295 11.4.1.1 Increasing demand for proteomics research and personalized medicine to boost segment growth 295 11.4.2 CAPILLARY ELECTROPHORESIS 298 11.4.2.1 Low diffusion coefficients of biomolecules and easy elimination of sample carryover between measurements to drive market 298 11.5 PROTEIN MICROARRAYS 302 11.5.1 INTEGRATED SYSTEMS 306 11.5.1.1 Integrated systems to enable high-throughput and reproducible analysis of proteins 306 11.5.2 MICROARRAY SCANNERS 309 11.5.2.1 Cost-effective and high-quality analysis to propel segment growth 309   11.5.3 ARRAYERS 313 11.5.3.1 Technological advancements to drive adoption of arrayers in large-scale projects 313 11.6 X-RAY CRYSTALLOGRAPHY 316 11.6.1 RISING NEED FOR HIGH-RESOLUTION INFORMATION ON PROTEIN STRUCTURES TO AUGMENT MARKET GROWTH 316 11.7 SURFACE PLASMON RESONANCE 319 11.7.1 INCREASING ABILITY TO BIND AFFINITIES AND KINETICS OF COMPLEXES TO PROPEL MARKET GROWTH 319 11.8 PROTEIN FRACTIONATION 323 11.8.1 PROTEIN FRACTIONATION TO ENABLE EFFECTIVE SEPARATION OF PROTEINS IN COMPLEX MIXTURES 323 11.9 OTHER INSTRUMENTATION TECHNOLOGIES 326 12 PROTEOMICS MARKET, BY SERVICE 330 12.1 INTRODUCTION 331 12.2 CORE PROTEOMICS SERVICES 331 12.2.1 PROTEIN IDENTIFICATION SERVICES 335 12.2.1.1 Outsourced mass spectrometry and complex-sample workflows to boost market growth 335 12.2.2 QUANTITATIVE PROTEOMICS SERVICES 339 12.2.2.1 Quantified protein profiling and translational model validation to drive market growth 339 12.2.3 PROTEIN CHARACTERIZATION SERVICES 342 12.2.3.1 Biologics complexity and comparability testing to drive market growth 342 12.2.4 PROTEIN PURIFICATION SERVICES 346 12.2.4.1 High-purity biologics and outsourced purification expertise to drive market 346 12.2.5 PROTEIN SEPARATION SERVICES 349 12.2.5.1 Complex sample analysis and biomarker research to augment segment growth 349 12.2.6 PROTEIN SEQUENCING SERVICES 353 12.2.6.1 Antibody development and outsourced sequence interpretation to drive market 353 12.2.7 CUSTOM ASSAY SERVICES 356 12.2.7.1 Biomarker specificity and outsourced assay design to drive market 356 12.3 BIOINFORMATICS SERVICES 360 12.3.1 SCALABLE DATA INTERPRETATION AND MULTI-OMICS INTEGRATION TO SPUR MARKET GROWTH 360   13 PROTEOMICS MARKET, BY SOFTWARE 364 13.1 INTRODUCTION 365 13.2 BIOINFORMATICS TOOLS 365 13.2.1 RISING DATA COMPLEXITY AND AI-ENABLED ANALYSIS TO AUGMENT MARKET GROWTH 365 13.3 BIOINFORMATICS DATABASES 369 13.3.1 EXPANDING CURATED PROTEIN KNOWLEDGEBASES AND MULTI-OMICS INTEGRATION TO DRIVE MARKET 369 14 PROTEOMICS MARKET, BY WORKFLOW 373 14.1 INTRODUCTION 374 14.2 SAMPLE PREPARATION 374 14.2.1 AUTOMATION, REPRODUCIBILITY, AND HIGH-THROUGHPUT BIOMARKER WORKFLOWS TO AUGMENT MARKET GROWTH 374 14.3 PROTEIN SEPARATION & FRACTIONATION 378 14.3.1 RISING DEMAND FOR DEEPER PROTEOME COVERAGE AND IMPROVED LC-MS SENSITIVITY TO DRIVE MARKET 378 14.4 PROTEIN IDENTIFICATION & QUANTIFICATION 381 14.4.1 HIGHER SENSITIVITY, DEEPER PROTEOME COVERAGE, AND SCALABLE QUANTIFICATION WORKFLOWS TO AUGMENT MARKET GROWTH 381 14.5 PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS 385 14.5.1 RISING BIOLOGICS COMPLEXITY AND DEMAND FOR STRUCTURE-FUNCTION INSIGHTS TO DRIVE MARKET 385 14.6 BIOINFORMATICS & DATA ANALYSIS 388 14.6.1 RISING DATA COMPLEXITY, DIA ADOPTION, AND AI-ENABLED INTERPRETATION TO DRIVE MARKET 388 15 PROTEOMICS MARKET, BY TYPE 392 15.1 INTRODUCTION 393 15.1.1 BULK PROTEOMICS 393 15.1.1.1 Large-cohort biomarker discovery, high-throughput protein profiling, and scalable multi-omics integration to drive market growth 393 15.1.2 TARGETED/AFFINITY PROTEOMICS 397 15.1.2.1 High-sensitivity protein panels and scalable biomarker validation to drive the market 397 15.1.3 SPATIAL PROTEOMICS 400 15.1.3.1 Emerging spatial biology workflows to drive market growth 400 15.1.4 SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS 404 15.1.4.1 Demand for ultra-sensitive and low-input protein analysis to drive market 404   16 PROTEOMICS MARKET, BY APPLICATION 408 16.1 INTRODUCTION 409 16.2 CLINICAL DIAGNOSTICS 409 16.2.1 CANCER 413 16.2.1.1 Precision oncology and high-sensitivity protein biomarker testing to propel market growth 413 16.2.2 INFECTIOUS DISEASES 417 16.2.2.1 Rapid pathogen identification to support market growth 417 16.2.3 DIABETES 420 16.2.3.1 Precision diabetes care and protein-based risk stratification to aid market growth 420 16.2.4 NEUROLOGICAL DISORDERS 424 16.2.4.1 Blood-based neuroprotein biomarkers to fuel market growth 424 16.2.5 AUTOIMMUNE DISEASES 427 16.2.5.1 Demand for immune-pathway biomarkers and flare monitoring to propel market growth 427 16.2.6 CARDIOVASCULAR DISEASES 431 16.2.6.1 Multi-protein cardiovascular risk profiling to drive growth 431 16.2.7 OTHER CLINICAL DIAGNOSTIC APPLICATIONS 434 16.3 DRUG DISCOVERY & DEVELOPMENT 438 16.3.1 TARGET DISCOVERY 442 16.3.1.1 High-throughput proteomics and AI-enabled target biology to support segment growth 442 16.3.2 LEAD IDENTIFICATION 445 16.3.2.1 Chemoproteomics and high-throughput protein profiling to propel growth 445 16.3.3 LEAD OPTIMIZATION 449 16.3.3.1 Need for optimizing drug efficacy and safety to spur segment growth 449 16.3.4 PRECLINICAL STUDIES 452 16.3.4.1 Translational safety biomarkers and pathway-level efficacy assessment to drive growth 452 16.4 OTHER APPLICATIONS 456 17 PROTEOMICS MARKET, BY END USER 460 17.1 INTRODUCTION 461 17.2 BIOPHARMACEUTICAL COMPANIES 461 17.2.1 PRECISION MEDICINE, BIOMARKER-LED R&D, AND POPULATION-SCALE PROTEOMICS TO DRIVE MARKET 461 17.3 ACADEMIC & RESEARCH INSTITUTES 465 17.3.1 SHARED CORE INFRASTRUCTURE AND MULTI-OMICS RESEARCH MEDICINE TO BOOST MARKET GROWTH 465 17.4 HOSPITALS 468 17.4.1 PRECISION DIAGNOSTICS AND HOSPITAL-BASED TRANSLATIONAL RESEARCH TO BOOST MARKET GROWTH 468 17.5 CLINICAL LABORATORIES 472 17.5.1 PROTEIN-BASED DIAGNOSTICS AND LABORATORY WORKFLOW AUTOMATION TO SUPPORT MARKET GROWTH 472 17.6 OTHER END USERS 475 18 PROTEOMICS MARKET, BY REGION 479 18.1 INTRODUCTION 480 18.2 NORTH AMERICA 480 18.2.1 US 492 18.2.1.1 Precision medicine, high-throughput platforms, and biomarker-driven drug development to drive the market growth. 492 18.2.2 CANADA 503 18.2.2.1 Precision oncology networks, standardized LC-MS workflows, and AI-enabled multiomics to drive the market growth 503 18.3 EUROPE 514 18.3.1 GERMANY 525 18.3.1.1 Well-established pharmaceutical industry and increased government funding to augment market growth 525 18.3.2 UK 536 18.3.2.1 Population biobanks, clinical cohorts, and high-throughput multiomics to drive market growth 536 18.3.3 FRANCE 547 18.3.3.1 National infrastructure, clinical biomarker programs, and multiomics collaboration to drive the market growth 547 18.3.4 SWITZERLAND 558 18.3.4.1 Pharma-led innovation, deep plasma proteomics, and translational multiomics to drive the market growth 558 18.3.5 ITALY 569 18.3.5.1 Clinical multiomics, biomarker research, and cross-border proteomics collaboration to drive the market growth 569 18.3.6 SPAIN 580 18.3.6.1 Spatial omics infrastructure, clinical collaboration, and high-throughput proteomics to drive the market growth 580 18.3.7 REST OF EUROPE 591 18.4 ASIA PACIFIC 602 18.4.1 CHINA 614 18.4.1.1 Precision medicine investment, automated LC-MS/MS workflows, and large-scale clinical proteomics to fuel market growth 614 18.4.2 JAPAN 625 18.4.2.1 Precision medicine, automated LC-MS/MS workflows, and clinical biomarker programs to drive market 625 18.4.3 INDIA 636 18.4.3.1 Biopharma R&D and LC-MS/MS adoption to support market growth 636 18.4.4 SOUTH KOREA 647 18.4.4.1 Biopharma innovation, high-plex protein profiling, and automated multiomics workflows to propel market growth 647 18.4.5 AUSTRALIA 658 18.4.5.1 Translational biomedicine, high-resolution LC-MS/MS, and automated protein analytics to favor market growth 658 18.4.6 REST OF ASIA PACIFIC 669 18.5 LATIN AMERICA 679 18.5.1 BRAZIL 690 18.5.1.1 Open LC-MS/MS infrastructure and translational biomarker programs to drive market 690 18.5.2 MEXICO 701 18.5.2.1 Oncology biomarker research to augment market growth 701 18.5.3 REST OF LATIN AMERICA 712 18.6 MIDDLE EAST 723 18.6.1 GCC COUNTRIES 734 18.6.1.1 Saudi Arabia 745 18.6.1.1.1 Biotechnology localization and clinical biomarker research to boost market growth 745 18.6.1.2 UAE 756 18.6.1.2.1 Multiomics infrastructure and public-private research partnerships to drive market 756 18.6.1.3 Rest of GCC Countries 767 18.6.2 REST OF MIDDLE EAST 778 18.7 AFRICA 789 18.7.1 BIOMARKER PLATFORM ADOPTION TO PROPEL MARKET GROWTH 789 19 COMPETITIVE LANDSCAPE 801 19.1 INTRODUCTION 801 19.2 KEY PLAYER STRATEGY/RIGHT TO WIN, 2021–2025 801 19.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEOMICS MARKET, JANUARY 2023-APRIL 2026 801 19.3 REVENUE ANALYSIS, 2021–2025 803 19.4 MARKET SHARE ANALYSIS, 2025 804 19.5 BRAND COMPARISON 807 19.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 808 19.6.1 STARS 808 19.6.2 EMERGING LEADERS 808 19.6.3 PERVASIVE PLAYERS 808 19.6.4 PARTICIPANTS 808 19.6.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 810 19.6.5.1 Company footprint 810 19.6.5.2 Region footprint 811 19.6.5.3 Instrumentation technology footprint 812 19.6.5.4 Reagent footprint 813 19.6.5.5 Service footprint 815 19.6.5.6 Software footprint 816 19.7 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 817 19.7.1 PROGRESSIVE COMPANIES 817 19.7.2 RESPONSIVE COMPANIES 817 19.7.3 DYNAMIC COMPANIES 817 19.7.4 STARTING BLOCKS 817 19.7.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025 819 19.7.5.1 Detailed list of key startup/SME players 819 19.7.5.2 Competitive benchmarking of startups/SMEs 820 19.8 COMPANY VALUATION AND FINANCIAL METRICS 821 19.8.1 COMPANY VALUATION 821 19.8.2 FINANCIAL METRICS 822 19.9 COMPETITIVE SCENARIO 822 19.9.1 PRODUCT LAUNCHES 822 19.9.2 DEALS 823 19.9.3 EXPANSIONS 824 20 COMPANY PROFILES 825 20.1 KEY PLAYERS 825 20.1.1 THERMO FISHER SCIENTIFIC INC. 825 20.1.1.1 Business overview 825 20.1.1.2 Products/Services/Solutions offered 826 20.1.1.3 Recent developments 839 20.1.1.3.1 Product launches 839 20.1.1.3.2 Deals 840 20.1.1.4 MnM view 840 20.1.1.4.1 Key strengths 840 20.1.1.4.2 Strategic choices 840 20.1.1.4.3 Weaknesses and competitive threats 840 20.1.2 AGILENT TECHNOLOGIES, INC. 841 20.1.2.1 Business overview 841 20.1.2.2 Products/Services/Solutions offered 842 20.1.2.3 Recent developments 847 20.1.2.3.1 Product launches 847 20.1.2.3.2 Deals 848 20.1.2.3.3 Expansions 849 20.1.2.4 MnM view 849 20.1.2.4.1 Key strengths 849 20.1.2.4.2 Strategic choices 849 20.1.2.4.3 Weaknesses and competitive threats 849   20.1.3 MERCK KGAA 850 20.1.3.1 Business overview 850 20.1.3.2 Products/Services/Solutions offered 851 20.1.3.3 Recent developments 854 20.1.3.3.1 Deals 854 20.1.3.4 MnM view 854 20.1.3.4.1 Key strengths 854 20.1.3.4.2 Strategic choices 854 20.1.3.4.3 Weaknesses and competitive threats 854 20.1.4 DANAHER CORPORATION 855 20.1.4.1 Business overview 855 20.1.4.2 Products/Services/Solutions offered 856 20.1.4.3 Recent developments 868 20.1.4.3.1 Product launches 868 20.1.4.3.2 Deals 869 20.1.4.4 MnM view 869 20.1.4.4.1 Key strengths 869 20.1.4.4.2 Strategic choices 869 20.1.4.4.3 Weaknesses and competitive threats 869 20.1.5 SHIMADZU CORPORATION 870 20.1.5.1 Business overview 870 20.1.5.2 Products/Services/Solutions offered 871 20.1.5.3 Recent developments 876 20.1.5.3.1 Product launches 876 20.1.5.3.2 Expansions 876 20.1.5.4 MnM view 877 20.1.5.4.1 Key strengths 877 20.1.5.4.2 Strategic choices 877 20.1.5.4.3 Weaknesses and competitive threats 877 20.1.6 WATERS CORPORATION 878 20.1.6.1 Business overview 878 20.1.6.2 Products/Services/Solutions offered 879 20.1.6.3 Recent developments 886 20.1.6.3.1 Product launches 886 20.1.6.3.2 Deals 886 20.1.7 BIO-RAD LABORATORIES, INC. 887 20.1.7.1 Business overview 887 20.1.7.2 Products/Services/Solutions offered 888   20.1.8 BRUKER 897 20.1.8.1 Business overview 897 20.1.8.2 Products/Services/Solutions offered 898 20.1.8.3 Recent developments 904 20.1.8.3.1 Product launches 904 20.1.8.3.2 Deals 905 20.1.9 REVVITY 906 20.1.9.1 Business overview 906 20.1.9.2 Products/Services/Solutions offered 907 20.1.9.3 Recent developments 910 20.1.9.3.1 Product launches 910 20.1.10 ILLUMINA, INC. 911 20.1.10.1 Business overview 911 20.1.10.2 Products/Services/Solutions offered 912 20.1.10.3 Recent developments 914 20.1.10.3.1 Deals 914 20.1.11 PROMEGA CORPORATION 915 20.1.11.1 Business overview 915 20.1.11.2 Products/Services/Solutions offered 915 20.1.12 EUROFINS SCIENTIFIC 919 20.1.12.1 Business overview 919 20.1.12.2 Products/Services/Solutions offered 920 20.1.12.3 Recent developments 921 20.1.12.3.1 Deals 921 20.1.13 QIAGEN 922 20.1.13.1 Business overview 922 20.1.13.2 Products/Services/Solutions offered 923 20.1.13.3 Recent developments 926 20.1.13.3.1 Product launches 926 20.1.13.3.2 Deals 927 20.1.14 CHARLES RIVER LABORATORIES 928 20.1.14.1 Business overview 928 20.1.14.2 Products/Services/Solutions offered 929 20.1.14.3 Recent developments 931 20.1.14.3.1 Product launches 931 20.1.14.3.2 Deals 932 20.1.15 PROTAGENE 933 20.1.15.1 Business overview 933 20.1.15.2 Products/Services/Solutions offered 933 20.1.16 BIO-TECHNE 936 20.1.16.1 Business overview 936 20.1.16.2 Products/Services/Solutions offered 937 20.1.17 AZENTA US INC. 939 20.1.17.1 Business overview 939 20.1.17.2 Products/Services/Solutions offered 940 20.1.18 QUANTERIX 941 20.1.18.1 Business overview 941 20.1.18.2 Products/Services/Solutions offered 942 20.1.19 PROTEOMICS INTERNATIONAL 943 20.1.19.1 Business overview 943 20.1.19.2 Products/Services/Solutions offered 944 20.1.20 HAMILTON COMPANY 945 20.1.20.1 Business overview 945 20.1.20.2 Products/Services/Solutions offered 945 20.1.20.3 Recent developments 946 20.1.20.3.1 Product launches 946 20.2 OTHER PLAYERS 947 20.2.1 CREATIVE PROTEOMICS 947 20.2.2 HORIBA, LTD. 949 20.2.3 LABVANTAGE-BIOMAX GMBH 950 20.2.4 FIOS GENOMICS 951 20.2.5 MEDGENOME 952 20.2.6 BIOGNOSYS AG 953 20.2.7 MACROGEN, INC. 954 20.2.8 CELL SIGNALING TECHNOLOGY, INC. 955 20.2.9 STANDARD BIOTOOLS 956 20.2.10 PIXELGEN TECHNOLOGIES 957 20.2.11 APPLIED BIOMICS 957 20.2.12 QUANTUM-SI INCORPORATED 958 20.2.13 ERISYON INC. 959 20.2.14 NAUTILUS BIOTECHNOLOGY, INC. 960 21 RESEARCH METHODOLOGY 961 21.1 RESEARCH DATA 961 21.1.1 SECONDARY DATA 961 21.1.1.1 Key data from secondary sources 961 21.1.2 PRIMARY DATA 962 21.1.2.1 Key data from primary sources 962 21.1.2.2 Key primary participants 963 21.1.2.3 Breakdown of primary interviews 963 21.1.2.4 Key industry insights 964 21.2 MARKET SIZE ESTIMATION 965 21.2.1 GLOBAL PROTEOMICS MARKET ESTIMATION, 2025 965 21.2.2 SEGMENTAL MARKET SIZE ESTIMATION 967 21.3 MARKET GROWTH RATE PROJECTIONS 969 21.4 DATA TRIANGULATION 971 21.5 FACTOR ANALYSIS 972 21.6 RESEARCH ASSUMPTIONS 972 21.7 RESEARCH LIMITATIONS AND RISK ASSESSMENT 973 22 APPENDIX 974 22.1 DISCUSSION GUIDE 974 22.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 979 22.3 CUSTOMIZATION OPTIONS 981 22.4 RELATED REPORTS 981 22.5 AUTHOR DETAILS 982
圖表清單 List of Tables & Figures
TABLE 1 PROTEOMICS MARKET: INCLUSIONS AND EXCLUSIONS 80 TABLE 2 PROTEOMICS MARKET: IMPACT ANALYSIS OF MARKET DYNAMICS 92 TABLE 3 PROTEOMICS MARKET: PORTER’S FIVE FORCES 100 TABLE 4 PROTEOMICS MARKET: ROLE OF PLAYERS IN ECOSYSTEM 106 TABLE 5 AVERAGE SELLING PRICE TREND OF INSTRUMENTATION, BY KEY PLAYER, 2023–2025 (USD) 108 TABLE 6 AVERAGE SELLING PRICE TREND OF REAGENTS, BY KEY PLAYER, 2023-2025 (USD) 109 TABLE 7 AVERAGE SELLING PRICE TREND OF INSTRUMENTATION, BY REGION, 2023–2025 (USD) 109 TABLE 8 AVERAGE SELLING PRICE TREND OF REAGENTS, BY REGION, 2023–2025 (USD) 110 TABLE 9 IMPORT DATA FOR HS CODE 9027.20-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 111 TABLE 10 EXPORT DATA FOR HS CODE 9027.20-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 112 TABLE 11 IMPORT DATA FOR HS CODE 9027.81-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 112 TABLE 12 EXPORT DATA FOR HS CODE 9027.81-COMPLIANT PRODUCTS, BY COUNTRY, 2021–2025 (USD THOUSAND) 113 TABLE 13 PROTEOMICS MARKET: LIST OF KEY CONFERENCES & EVENTS, JANUARY 2026–MARCH 2027 114 TABLE 14 RECIPROCAL TARIFF RATES ADJUSTED BY US 117 TABLE 15 CRITICAL COMPONENTS LIKELY EXPOSED TO TARIFF CHANGES 119 TABLE 16 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 122 TABLE 17 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 123 TABLE 18 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 124 TABLE 19 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 124 TABLE 20 NUMBER OF PATENTS FILED, BY DOCUMENT TYPE, 2015–2025 133 TABLE 21 LIST OF KEY PATENTS IN THE PROTEOMICS MARKET, 2023-2025 134 TABLE 22 CASE STUDIES OF AI IMPLEMENTATION IN PROTEOMICS MARKET 137 TABLE 23 CLIENTS’ READINESS TO ADOPT GENERATIVE AI IN PROTEOMICS MARKET 138 TABLE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 141 TABLE 25 KEY BUYING CRITERIA, BY END USER 141 TABLE 26 PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 145 TABLE 27 PROTEOMICS INSTRUMENTS MARKET, BY REGION, 2024–2031 (USD MILLION) 146 TABLE 28 NORTH AMERICA: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 29 EUROPE: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 30 ASIA PACIFIC: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 31 LATIN AMERICA: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 32 MIDDLE EAST: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 33 GCC COUNTRIES: PROTEOMICS INSTRUMENTS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 148 TABLE 34 PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 149 TABLE 35 NORTH AMERICA: PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 36 EUROPE: PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 37 ASIA PACIFIC: PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 38 LATIN AMERICA: PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 39 MIDDLE EAST: PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 40 GCC COUNTRIES: PROTEOMICS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 41 PROTEOMICS SOFTWARE MARKET, BY REGION, 2024–2031 (USD MILLION) 153 TABLE 42 NORTH AMERICA: PROTEOMICS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 43 EUROPE: PROTEOMICS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 44 ASIA PACIFIC: PROTEOMICS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 45 LATIN AMERICA: PROTEOMICS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 46 MIDDLE EAST: PROTEOMICS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 47 GCC COUNTRIES: PROTEOMICS SOFTWARE MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 48 PROTEOMICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 156 TABLE 49 NORTH AMERICA: PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 50 EUROPE: PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 51 ASIA PACIFIC: PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 52 LATIN AMERICA: PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 53 MIDDLE EAST: PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 54 GCC COUNTRIES: PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 55 PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 161 TABLE 56 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 162 TABLE 57 PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 162 TABLE 58 NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 59 EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 60 ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 61 LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 164 TABLE 62 MIDDLE EAST: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 63 GCC COUNTRIES: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 64 IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY REGION, 2024–2031 (USD MILLION) 166 TABLE 65 NORTH AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 66 EUROPE: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 67 ASIA PACIFIC: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 68 LATIN AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 69 MIDDLE EAST: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 70 GCC COUNTRIES: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ANTIBODIES & HIGH-AFFINITY BINDERS, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 71 IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY REGION, 2024–2031 (USD MILLION) 169 TABLE 72 NORTH AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 73 EUROPE: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 74 ASIA PACIFIC: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 75 LATIN AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 76 MIDDLE EAST: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 77 GCC COUNTRIES: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR ASSAY KITS, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 78 IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 173 TABLE 79 NORTH AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 80 EUROPE: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 81 ASIA PACIFIC: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 82 LATIN AMERICA: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 83 MIDDLE EAST: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 84 GCC COUNTRIES: IMMUNOASSAY REAGENTS & CONSUMABLES MARKET FOR OTHER IMMUNOASSAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 85 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 176 TABLE 86 PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 177 TABLE 87 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 177 TABLE 88 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 89 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 90 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 91 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 92 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 179 TABLE 93 SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY REGION, 2024–2031 (USD MILLION) 180 TABLE 94 NORTH AMERICA: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 95 EUROPE: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 96 ASIA PACIFIC: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 97 LATIN AMERICA: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 98 MIDDLE EAST: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 99 GCC COUNTRIES: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR MASS TAGGING & LABELING KITS, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 100 SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY REGION, 2024–2031 (USD MILLION) 183 TABLE 101 NORTH AMERICA: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 102 EUROPE: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 103 ASIA PACIFIC: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 104 LATIN AMERICA: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 105 MIDDLE EAST: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 106 GCC COUNTRIES: SPECTROSCOPY REAGENTS & CONSUMABLES MARKET FOR ENZYMES, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 107 OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 186 TABLE 108 NORTH AMERICA: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 109 EUROPE: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 110 ASIA PACIFIC: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 111 LATIN AMERICA: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 112 MIDDLE EAST: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 113 GCC COUNTRIES: OTHER SPECTROSCOPY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 114 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 189 TABLE 115 PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 190 TABLE 116 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 117 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 118 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 119 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 192 TABLE 120 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 192 TABLE 121 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 192 TABLE 122 CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY REGION, 2024–2031 (USD MILLION) 193 TABLE 123 NORTH AMERICA: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024–2031 (USD MILLION) 193 TABLE 124 EUROPE: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 125 ASIA PACIFIC: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 126 LATIN AMERICA: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 127 MIDDLE EAST: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 128 GCC COUNTRIES: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR ANALYTICAL COLUMNS, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 129 CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY REGION, 2024–2031 (USD MILLION) 196 TABLE 130 NORTH AMERICA: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 131 EUROPE: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 132 ASIA PACIFIC: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 133 LATIN AMERICA: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 134 MIDDLE EAST: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 135 GCC COUNTRIES: CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET FOR REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 136 OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 199 TABLE 137 NORTH AMERICA: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 138 EUROPE: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 139 ASIA PACIFIC: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 140 LATIN AMERICA: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 141 MIDDLE EAST: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 142 GCC COUNTRIES: OTHER CHROMATOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 143 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 202 TABLE 144 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 203 TABLE 145 PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 203 TABLE 146 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 147 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 204 TABLE 148 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 149 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 150 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 205 TABLE 151 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 206 TABLE 152 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY REGION, 2024–2031 (USD MILLION) 207 TABLE 153 NORTH AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 207 TABLE 154 EUROPE: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 155 ASIA PACIFIC: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 208 TABLE 156 LATIN AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 157 MIDDLE EAST: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 158 GCC COUNTRIES: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR BIOCHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 209 TABLE 159 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY REGION, 2024–2031 (USD MILLION) 210 TABLE 160 NORTH AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 161 EUROPE: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 211 TABLE 162 ASIA PACIFIC: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 163 LATIN AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 212 TABLE 164 MIDDLE EAST: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 213 TABLE 165 GCC COUNTRIES: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR LAB-ON-CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 213 TABLE 166 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY REGION, 2024–2031 (USD MILLION) 214 TABLE 167 NORTH AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 214 TABLE 168 EUROPE: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 169 ASIA PACIFIC: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 215 TABLE 170 LATIN AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 171 MIDDLE EAST: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 172 GCC COUNTRIES: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR PROTEIN CHIPS, BY COUNTRY, 2024–2031 (USD MILLION) 216 TABLE 173 PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY REGION, 2024–2031 (USD MILLION) 217 TABLE 174 NORTH AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 175 EUROPE: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 218 TABLE 176 ASIA PACIFIC: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 177 LATIN AMERICA: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 219 TABLE 178 MIDDLE EAST: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 220 TABLE 179 GCC COUNTRIES: PROTEIN MICROARRAY REAGENTS & CONSUMABLES MARKET FOR DETECTION REAGENTS, BY COUNTRY, 2024–2031 (USD MILLION) 220 TABLE 180 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 181 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 221 TABLE 182 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 222 TABLE 183 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 222 TABLE 184 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 185 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 186 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 223 TABLE 187 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 224 TABLE 188 X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY REGION, 2024–2031 (USD MILLION) 225 TABLE 189 NORTH AMERICA: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024–2031 (USD MILLION) 225 TABLE 190 EUROPE: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024–2031 (USD MILLION) 226 TABLE 191 ASIA PACIFIC: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024–2031 (USD MILLION) 226 TABLE 192 LATIN AMERICA: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 193 MIDDLE EAST: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 194 GCC COUNTRIES: X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET FOR CRYSTALLIZATION SCREENS, BY COUNTRY, 2024–2031 (USD MILLION) 227 TABLE 195 OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 228 TABLE 196 NORTH AMERICA: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 228 TABLE 197 EUROPE: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 229 TABLE 198 ASIA PACIFIC: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 229 TABLE 199 LATIN AMERICA: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 200 MIDDLE EAST: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 201 GCC COUNTRIES: OTHER X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 230 TABLE 202 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 231 TABLE 203 PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 232 TABLE 204 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 232 TABLE 205 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 206 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 233 TABLE 207 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 208 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 209 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 234 TABLE 210 ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY REGION, 2024–2031 (USD MILLION) 235 TABLE 211 NORTH AMERICA: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024–2031 (USD MILLION) 236 TABLE 212 EUROPE: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024–2031 (USD MILLION) 236 TABLE 213 ASIA PACIFIC: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 214 LATIN AMERICA: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024–2031 (USD MILLION) 237 TABLE 215 MIDDLE EAST: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 216 GCC COUNTRIES: ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET FOR ELECTROPHORESIS STAINS & DYES, BY COUNTRY, 2024–2031 (USD MILLION) 238 TABLE 217 OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 239 TABLE 218 NORTH AMERICA: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 239 TABLE 219 EUROPE: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 240 TABLE 220 ASIA PACIFIC: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 240 TABLE 221 LATIN AMERICA: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 222 MIDDLE EAST: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 223 GCC COUNTRIES: OTHER ELECTROPHORESIS REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 241 TABLE 224 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 242 TABLE 225 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 243 TABLE 226 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 243 TABLE 227 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 244 TABLE 228 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 244 TABLE 229 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 230 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 245 TABLE 231 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 246 TABLE 232 PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY REGION, 2024–2031 (USD MILLION) 246 TABLE 233 NORTH AMERICA: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY, 2024–2031 (USD MILLION) 247 TABLE 234 EUROPE: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY, 2024–2031 (USD MILLION) 247 TABLE 235 ASIA PACIFIC: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 236 LATIN AMERICA: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY, 2024–2031 (USD MILLION) 248 TABLE 237 MIDDLE EAST: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY, 2024–2031 (USD MILLION) 249 TABLE 238 GCC COUNTRIES: PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET FOR PROTEIN FRACTIONATION & ENRICHMENT KITS, BY COUNTRY, 2024–2031 (USD MILLION) 249 TABLE 239 OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY REGION, 2024–2031 (USD MILLION) 250 TABLE 240 NORTH AMERICA: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 250 TABLE 241 EUROPE: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 251 TABLE 242 ASIA PACIFIC: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 251 TABLE 243 LATIN AMERICA: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 244 MIDDLE EAST: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 245 GCC COUNTRIES: OTHER PROTEIN FRACTIONATION REAGENTS & CONSUMABLES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 252 TABLE 246 PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2024–2031 (USD MILLION) 253 TABLE 247 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 254 TABLE 248 EUROPE: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 254 TABLE 249 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 250 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 251 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 255 TABLE 252 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2024–2031 (USD MILLION) 256 TABLE 253 PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 258 TABLE 254 PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 259 TABLE 255 PROTEOMICS MARKET FOR SPECTROSCOPY, BY REGION, 2024–2031 (USD MILLION) 259 TABLE 256 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 260 TABLE 257 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 260 TABLE 258 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 261 TABLE 259 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 261 TABLE 260 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 261 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 262 TABLE 262 MASS SPECTROMETRY MARKET, BY REGION, 2024–2031 (USD MILLION) 263 TABLE 263 NORTH AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 264 TABLE 264 EUROPE: MASS SPECTROMETRY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 264 TABLE 265 ASIA PACIFIC: MASS SPECTROMETRY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 265 TABLE 266 LATIN AMERICA: MASS SPECTROMETRY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 265 TABLE 267 MIDDLE EAST: MASS SPECTROMETRY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 265 TABLE 268 GCC COUNTRIES: MASS SPECTROMETRY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 266 TABLE 269 NMR SPECTROSCOPY MARKET, BY REGION, 2024–2031 (USD MILLION) 267 TABLE 270 NORTH AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 267 TABLE 271 EUROPE: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 268 TABLE 272 ASIA PACIFIC: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 268 TABLE 273 LATIN AMERICA: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 269 TABLE 274 MIDDLE EAST: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 269 TABLE 275 GCC COUNTRIES: NMR SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 269 TABLE 276 CD SPECTROSCOPY MARKET, BY REGION, 2024–2031 (USD MILLION) 270 TABLE 277 NORTH AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 271 TABLE 278 EUROPE: CD SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 271 TABLE 279 ASIA PACIFIC: CD SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 272 TABLE 280 LATIN AMERICA: CD SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 272 TABLE 281 MIDDLE EAST: CD SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 272 TABLE 282 GCC COUNTRIES: CD SPECTROSCOPY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 273 TABLE 283 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 273 TABLE 284 PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY REGION, 2024–2031 (USD MILLION) 274 TABLE 285 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 274 TABLE 286 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 275 TABLE 287 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 275 TABLE 288 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 276 TABLE 289 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 276 TABLE 290 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 276 TABLE 291 HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY REGION, 2024–2031 (USD MILLION) 277 TABLE 292 NORTH AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 278 TABLE 293 EUROPE: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 278 TABLE 294 ASIA PACIFIC: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 279 TABLE 295 LATIN AMERICA: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 279 TABLE 296 MIDDLE EAST: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 280 TABLE 297 GCC COUNTRIES: HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 280 TABLE 298 ION CHROMATOGRAPHY MARKET, BY REGION, 2024–2031 (USD MILLION) 281 TABLE 299 NORTH AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 281 TABLE 300 EUROPE: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 282 TABLE 301 ASIA PACIFIC: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 282 TABLE 302 LATIN AMERICA: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 283 TABLE 303 MIDDLE EAST: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 283 TABLE 304 GCC COUNTRIES: ION CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 283 TABLE 305 AFFINITY CHROMATOGRAPHY MARKET, BY REGION, 2024–2031 (USD MILLION) 284 TABLE 306 NORTH AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 285 TABLE 307 EUROPE: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 285 TABLE 308 ASIA PACIFIC: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 286 TABLE 309 LATIN AMERICA: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 286 TABLE 310 MIDDLE EAST: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 287 TABLE 311 GCC COUNTRIES: AFFINITY CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 287 TABLE 312 SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY REGION, 2024–2031 (USD MILLION) 288 TABLE 313 NORTH AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 288 TABLE 314 EUROPE: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 289 TABLE 315 ASIA PACIFIC: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 289 TABLE 316 LATIN AMERICA: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 317 MIDDLE EAST: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 318 GCC COUNTRIES: SUPERCRITICAL FLUID CHROMATOGRAPHY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 290 TABLE 319 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 291 TABLE 320 PROTEOMICS MARKET FOR ELECTROPHORESIS, BY REGION, 2024–2031 (USD MILLION) 292 TABLE 321 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 292 TABLE 322 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 293 TABLE 323 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 293 TABLE 324 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 294 TABLE 325 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 294 TABLE 326 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY COUNTRY, 2024–2031 (USD MILLION) 294 TABLE 327 GEL ELECTROPHORESIS MARKET, BY REGION, 2024–2031 (USD MILLION) 295 TABLE 328 NORTH AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 296 TABLE 329 EUROPE: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 296 TABLE 330 ASIA PACIFIC: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 297 TABLE 331 LATIN AMERICA: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 297 TABLE 332 MIDDLE EAST: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 298 TABLE 333 GCC COUNTRIES: GEL ELECTROPHORESIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 298 TABLE 334 CAPILLARY ELECTROPHORESIS MARKET, BY REGION, 2024–2031 (USD MILLION) 299 TABLE 335 NORTH AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 299 TABLE 336 EUROPE: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 300 TABLE 337 ASIA PACIFIC: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 300 TABLE 338 LATIN AMERICA: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 301 TABLE 339 MIDDLE EAST: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 301 TABLE 340 GCC COUNTRIES: CAPILLARY ELECTROPHORESIS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 301 TABLE 341 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 302 TABLE 342 PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY REGION, 2024–2031 (USD MILLION) 303 TABLE 343 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 303 TABLE 344 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 304 TABLE 345 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 304 TABLE 346 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 305 TABLE 347 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 305 TABLE 348 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY COUNTRY, 2024–2031 (USD MILLION) 305 TABLE 349 INTEGRATED SYSTEMS MARKET, BY REGION, 2024–2031 (USD MILLION) 306 TABLE 350 NORTH AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 307 TABLE 351 EUROPE: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 307 TABLE 352 ASIA PACIFIC: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 308 TABLE 353 LATIN AMERICA: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 308 TABLE 354 MIDDLE EAST: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 308 TABLE 355 GCC COUNTRIES: INTEGRATED SYSTEMS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 309 TABLE 356 MICROARRAY SCANNERS MARKET, BY REGION, 2024–2031 (USD MILLION) 310 TABLE 357 NORTH AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 310 TABLE 358 EUROPE: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 311 TABLE 359 ASIA PACIFIC: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 311 TABLE 360 LATIN AMERICA: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 312 TABLE 361 MIDDLE EAST: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 312 TABLE 362 GCC COUNTRIES: MICROARRAY SCANNERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 312 TABLE 363 ARRAYERS MARKET, BY REGION, 2024–2031 (USD MILLION) 313 TABLE 364 NORTH AMERICA: ARRAYERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 313 TABLE 365 EUROPE: ARRAYERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 314 TABLE 366 ASIA PACIFIC: ARRAYERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 314 TABLE 367 LATIN AMERICA: ARRAYERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 315 TABLE 368 MIDDLE EAST: ARRAYERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 315 TABLE 369 GCC COUNTRIES: ARRAYERS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 315 TABLE 370 PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY REGION, 2024–2031 (USD MILLION) 316 TABLE 371 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 317 TABLE 372 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 317 TABLE 373 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 318 TABLE 374 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 318 TABLE 375 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 319 TABLE 376 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY, BY COUNTRY, 2024–2031 (USD MILLION) 319 TABLE 377 PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY REGION, 2024–2031 (USD MILLION) 320 TABLE 378 NORTH AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2024–2031 (USD MILLION) 320 TABLE 379 EUROPE: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2024–2031 (USD MILLION) 321 TABLE 380 ASIA PACIFIC: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2024–2031 (USD MILLION) 321 TABLE 381 LATIN AMERICA: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2024–2031 (USD MILLION) 322 TABLE 382 MIDDLE EAST: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2024–2031 (USD MILLION) 322 TABLE 383 GCC COUNTRIES: PROTEOMICS MARKET FOR SURFACE PLASMON RESONANCE, BY COUNTRY, 2024–2031 (USD MILLION) 322 TABLE 384 PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY REGION, 2024–2031 (USD MILLION) 323 TABLE 385 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 324 TABLE 386 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 324 TABLE 387 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 325 TABLE 388 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 325 TABLE 389 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 326 TABLE 390 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 326 TABLE 391 PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY REGION, 2024–2031 (USD MILLION) 327 TABLE 392 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 327 TABLE 393 EUROPE: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 328 TABLE 394 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 328 TABLE 395 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 329 TABLE 396 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 329 TABLE 397 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER INSTRUMENTATION TECHNOLOGIES, BY COUNTRY, 2024–2031 (USD MILLION) 329 TABLE 398 PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 331 TABLE 399 CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 332 TABLE 400 CORE PROTEOMICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 332 TABLE 401 NORTH AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 333 TABLE 402 EUROPE: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 333 TABLE 403 ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 334 TABLE 404 LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 334 TABLE 405 MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 334 TABLE 406 GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 335 TABLE 407 PROTEIN IDENTIFICATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 336 TABLE 408 NORTH AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 336 TABLE 409 EUROPE: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 337 TABLE 410 ASIA PACIFIC: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 337 TABLE 411 LATIN AMERICA: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 338 TABLE 412 MIDDLE EAST: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 338 TABLE 413 GCC COUNTRIES: PROTEIN IDENTIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 338 TABLE 414 QUANTITATIVE PROTEOMICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 339 TABLE 415 NORTH AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 340 TABLE 416 EUROPE: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 340 TABLE 417 ASIA PACIFIC: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 341 TABLE 418 LATIN AMERICA: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 341 TABLE 419 MIDDLE EAST: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 342 TABLE 420 GCC COUNTRIES: QUANTITATIVE PROTEOMICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 342 TABLE 421 PROTEIN CHARACTERIZATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 343 TABLE 422 NORTH AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 343 TABLE 423 EUROPE: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 344 TABLE 424 ASIA PACIFIC: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 344 TABLE 425 LATIN AMERICA: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY 2024–2031 (USD MILLION) 345 TABLE 426 MIDDLE EAST: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 345 TABLE 427 GCC COUNTRIES: PROTEIN CHARACTERIZATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 345 TABLE 428 PROTEIN PURIFICATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 346 TABLE 429 NORTH AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 347 TABLE 430 EUROPE: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 347 TABLE 431 ASIA PACIFIC: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 348 TABLE 432 LATIN AMERICA: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 348 TABLE 433 MIDDLE EAST: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 349 TABLE 434 GCC COUNTRIES: PROTEIN PURIFICATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 349 TABLE 435 PROTEIN SEPARATION SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 350 TABLE 436 NORTH AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 350 TABLE 437 EUROPE: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 351 TABLE 438 ASIA PACIFIC: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 351 TABLE 439 LATIN AMERICA: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 352 TABLE 440 MIDDLE EAST: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 352 TABLE 441 GCC COUNTRIES: PROTEIN SEPARATION SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 352 TABLE 442 PROTEIN SEQUENCING SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 353 TABLE 443 NORTH AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 354 TABLE 444 EUROPE: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 354 TABLE 445 ASIA PACIFIC: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 355 TABLE 446 LATIN AMERICA: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 355 TABLE 447 MIDDLE EAST: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 356 TABLE 448 GCC COUNTRIES: PROTEIN SEQUENCING SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 356 TABLE 449 CUSTOM ASSAY SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 357 TABLE 450 NORTH AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 357 TABLE 451 EUROPE: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 358 TABLE 452 ASIA PACIFIC: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 358 TABLE 453 LATIN AMERICA: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 359 TABLE 454 MIDDLE EAST: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 359 TABLE 455 GCC COUNTRIES: CUSTOM ASSAY SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 359 TABLE 456 BIOINFORMATICS SERVICES MARKET, BY REGION, 2024–2031 (USD MILLION) 360 TABLE 457 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 361 TABLE 458 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 361 TABLE 459 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 362 TABLE 460 LATIN AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 362 TABLE 461 MIDDLE EAST: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 363 TABLE 462 GCC COUNTRIES: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 363 TABLE 463 PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 365 TABLE 464 PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY REGION, 2024–2031 (USD MILLION) 366 TABLE 465 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2024–2031 (USD MILLION) 366 TABLE 466 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2024–2031 (USD MILLION) 367 TABLE 467 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2024–2031 (USD MILLION) 367 TABLE 468 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2024–2031 (USD MILLION) 368 TABLE 469 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2024–2031 (USD MILLION) 368 TABLE 470 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS TOOLS, BY COUNTRY, 2024–2031 (USD MILLION) 368 TABLE 471 PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY REGION, 2024–2031 (USD MILLION) 369 TABLE 472 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2024–2031 (USD MILLION) 370 TABLE 473 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2024–2031 (USD MILLION) 370 TABLE 474 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2024–2031 (USD MILLION) 371 TABLE 475 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2024–2031 (USD MILLION) 371 TABLE 476 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2024–2031 (USD MILLION) 372 TABLE 477 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS DATABASES, BY COUNTRY, 2024–2031 (USD MILLION) 372 TABLE 478 PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 374 TABLE 479 PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY REGION, 2024–2031 (USD MILLION) 375 TABLE 480 NORTH AMERICA: PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 375 TABLE 481 EUROPE: PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 376 TABLE 482 ASIA PACIFIC: PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 376 TABLE 483 LATIN AMERICA: PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 377 TABLE 484 MIDDLE EAST: PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 377 TABLE 485 GCC COUNTRIES: PROTEOMICS MARKET FOR SAMPLE PREPARATION, BY COUNTRY, 2024–2031 (USD MILLION) 377 TABLE 486 PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY REGION, 2024–2031 (USD MILLION) 378 TABLE 487 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 379 TABLE 488 EUROPE: PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 379 TABLE 489 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 380 TABLE 490 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 380 TABLE 491 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 381 TABLE 492 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN SEPARATION & FRACTIONATION, BY COUNTRY, 2024–2031 (USD MILLION) 381 TABLE 493 PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY REGION, 2024–2031 (USD MILLION) 382 TABLE 494 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 382 TABLE 495 EUROPE: PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 383 TABLE 496 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 383 TABLE 497 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 384 TABLE 498 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 384 TABLE 499 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN IDENTIFICATION & QUANTIFICATION, BY COUNTRY, 2024–2031 (USD MILLION) 384 TABLE 500 PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 385 TABLE 501 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 386 TABLE 502 EUROPE: PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 386 TABLE 503 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 387 TABLE 504 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 387 TABLE 505 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 388 TABLE 506 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN CHARACTERIZATION & STRUCTURAL ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 388 TABLE 507 PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS, BY REGION, 2024–2031 (USD MILLION) 389 TABLE 508 NORTH AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 389 TABLE 509 EUROPE: PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 390 TABLE 510 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 390 TABLE 511 LATIN AMERICA: PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 391 TABLE 512 MIDDLE EAST: PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 391 TABLE 513 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOINFORMATICS & DATA ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 391 TABLE 514 PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 393 TABLE 515 PROTEOMICS MARKET FOR BULK PROTEOMICS, BY REGION 2024–2031 (USD MILLION) 394 TABLE 516 NORTH AMERICA: PROTEOMICS MARKET FOR BULK PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 394 TABLE 517 EUROPE: PROTEOMICS MARKET FOR BULK PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 395 TABLE 518 ASIA PACIFIC: PROTEOMICS MARKET FOR BULK PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 395 TABLE 519 LATIN AMERICA: PROTEOMICS MARKET FOR BULK PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 396 TABLE 520 MIDDLE EAST: PROTEOMICS MARKET FOR BULK PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 396 TABLE 521 GCC COUNTRIES: PROTEOMICS MARKET FOR BULK PROTEOMICS, BY COUNTRY 2024–2031 (USD MILLION) 396 TABLE 522 PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS, BY REGION, 2024–2031 (USD MILLION) 397 TABLE 523 NORTH AMERICA: PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 398 TABLE 524 EUROPE: PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 398 TABLE 525 ASIA PACIFIC: PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 399 TABLE 526 LATIN AMERICA: PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 399 TABLE 527 MIDDLE EAST: PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 400 TABLE 528 GCC COUNTRIES: PROTEOMICS MARKET FOR TARGETED/AFFINITY PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 400 TABLE 529 PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY REGION, 2024–2031 (USD MILLION) 401 TABLE 530 NORTH AMERICA: PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 401 TABLE 531 EUROPE: PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 402 TABLE 532 ASIA PACIFIC: PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 402 TABLE 533 LATIN AMERICA: PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 403 TABLE 534 MIDDLE EAST: PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 403 TABLE 535 GCC COUNTRIES: PROTEOMICS MARKET FOR SPATIAL PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 403 TABLE 536 PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY REGION, 2024–2031 (USD MILLION) 404 TABLE 537 NORTH AMERICA: PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 405 TABLE 538 EUROPE: PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 405 TABLE 539 ASIA PACIFIC: PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 406 TABLE 540 LATIN AMERICA: PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 406 TABLE 541 MIDDLE EAST: PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 407 TABLE 542 GCC COUNTRIES: PROTEOMICS MARKET FOR SINGLE MOLECULE PROTEOMICS/NEXT GENERATION PROTEOMICS, BY COUNTRY, 2024–2031 (USD MILLION) 407 TABLE 543 PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 409 TABLE 544 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 410 TABLE 545 PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2024–2031 (USD MILLION) 410 TABLE 546 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 411 TABLE 547 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 411 TABLE 548 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 412 TABLE 549 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 412 TABLE 550 MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 412 TABLE 551 GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2024–2031 (USD MILLION) 413 TABLE 552 CANCER CLINICAL DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 414 TABLE 553 NORTH AMERICA: CANCER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 414 TABLE 554 EUROPE: CANCER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 415 TABLE 555 ASIA PACIFIC: CANCER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 415 TABLE 556 LATIN AMERICA: CANCER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 416 TABLE 557 MIDDLE EAST: CANCER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 416 TABLE 558 GCC COUNTRIES: CANCER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 416 TABLE 559 INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 417 TABLE 560 NORTH AMERICA: INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 418 TABLE 561 EUROPE: INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 418 TABLE 562 ASIA PACIFIC: INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 419 TABLE 563 LATIN AMERICA: INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 419 TABLE 564 MIDDLE EAST: INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 420 TABLE 565 GCC COUNTRIES: INFECTIOUS DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 420 TABLE 566 DIABETES CLINICAL DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 421 TABLE 567 NORTH AMERICA: DIABETES CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 421 TABLE 568 EUROPE: DIABETES CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 422 TABLE 569 ASIA PACIFIC: DIABETES CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 422 TABLE 570 LATIN AMERICA: DIABETES CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 423 TABLE 571 MIDDLE EAST: DIABETES CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 423 TABLE 572 GCC COUNTRIES: DIABETES CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 423 TABLE 573 NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 424 TABLE 574 NORTH AMERICA: NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 425 TABLE 575 EUROPE: NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 425 TABLE 576 ASIA PACIFIC: NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 426 TABLE 577 LATIN AMERICA: NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 426 TABLE 578 MIDDLE EAST: NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 427 TABLE 579 GCC COUNTRIES: NEUROLOGICAL DISORDER CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 427 TABLE 580 AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 428 TABLE 581 NORTH AMERICA: AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 428 TABLE 582 EUROPE: AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 429 TABLE 583 ASIA PACIFIC: AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 429 TABLE 584 LATIN AMERICA: AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 430 TABLE 585 MIDDLE EAST: AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 430 TABLE 586 GCC COUNTRIES: AUTOIMMUNE DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 430 TABLE 587 CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY REGION, 2024–2031 (USD MILLION) 431 TABLE 588 NORTH AMERICA: CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 432 TABLE 589 EUROPE: CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 432 TABLE 590 ASIA PACIFIC: CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 433 TABLE 591 LATIN AMERICA: CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 433 TABLE 592 MIDDLE EAST: CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 434 TABLE 593 GCC COUNTRIES: CARDIOVASCULAR DISEASE CLINICAL DIAGNOSTICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 434 TABLE 594 OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY REGION, 2024–2031 (USD MILLION) 435 TABLE 595 NORTH AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 435 TABLE 596 EUROPE: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 436 TABLE 597 ASIA PACIFIC: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 436 TABLE 598 LATIN AMERICA: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 437 TABLE 599 MIDDLE EAST: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 437 TABLE 600 GCC COUNTRIES: OTHER CLINICAL DIAGNOSTIC APPLICATIONS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 437 TABLE 601 PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 438 TABLE 602 PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2024–2031 (USD MILLION) 439 TABLE 603 NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 439 TABLE 604 EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 440 TABLE 605 ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 440 TABLE 606 LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 441 TABLE 607 MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 441 TABLE 608 GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2024–2031 (USD MILLION) 441 TABLE 609 TARGET DISCOVERY MARKET, BY REGION, 2024–2031 (USD MILLION) 442 TABLE 610 NORTH AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 443 TABLE 611 EUROPE: TARGET DISCOVERY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 443 TABLE 612 ASIA PACIFIC: TARGET DISCOVERY MARKET, BY COUNTRY , 2024–2031 (USD MILLION) 444 TABLE 613 LATIN AMERICA: TARGET DISCOVERY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 444 TABLE 614 MIDDLE EAST: TARGET DISCOVERY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 444 TABLE 615 GCC COUNTRIES: TARGET DISCOVERY MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 445 TABLE 616 LEAD IDENTIFICATION MARKET, BY REGION, 2024–2031 (USD MILLION) 446 TABLE 617 NORTH AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 446 TABLE 618 EUROPE: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 447 TABLE 619 ASIA PACIFIC: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 447 TABLE 620 LATIN AMERICA: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 448 TABLE 621 MIDDLE EAST: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 448 TABLE 622 GCC COUNTRIES: LEAD IDENTIFICATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 448 TABLE 623 LEAD OPTIMIZATION MARKET, BY REGION, 2024–2031 (USD MILLION) 449 TABLE 624 NORTH AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 450 TABLE 625 EUROPE: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 450 TABLE 626 ASIA PACIFIC: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 451 TABLE 627 LATIN AMERICA: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 451 TABLE 628 MIDDLE EAST: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 451 TABLE 629 GCC COUNTRIES: LEAD OPTIMIZATION MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 452 TABLE 630 PRECLINICAL STUDIES MARKET, BY REGION, 2024–2031 (USD MILLION) 453 TABLE 631 NORTH AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 453 TABLE 632 EUROPE: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 454 TABLE 633 ASIA PACIFIC: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 454 TABLE 634 LATIN AMERICA: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 455 TABLE 635 MIDDLE EAST: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 455 TABLE 636 GCC COUNTRIES: PRECLINICAL STUDIES MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 455 TABLE 637 PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2024–2031 (USD MILLION) 456 TABLE 638 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 457 TABLE 639 EUROPE: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 457 TABLE 640 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 458 TABLE 641 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 458 TABLE 642 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 459 TABLE 643 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2024–2031 (USD MILLION) 459 TABLE 644 PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 461 TABLE 645 PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY REGION, 2024–2031 (USD MILLION) 462 TABLE 646 NORTH AMERICA: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 462 TABLE 647 EUROPE: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 463 TABLE 648 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 463 TABLE 649 LATIN AMERICA: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 464 TABLE 650 MIDDLE EAST: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 464 TABLE 651 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2024–2031 (USD MILLION) 464 TABLE 652 PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2024–2031 (USD MILLION) 465 TABLE 653 NORTH AMERICA: PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 466 TABLE 654 EUROPE: PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 466 TABLE 655 ASIA PACIFIC: PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 467 TABLE 656 LATIN AMERICA: PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 467 TABLE 657 MIDDLE EAST: PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 468 TABLE 658 GCC COUNTRIES: PROTEOMICS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2024–2031 (USD MILLION) 468 TABLE 659 PROTEOMICS MARKET FOR HOSPITALS, BY REGION, 2024–2031 (USD MILLION) 469 TABLE 660 NORTH AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 469 TABLE 661 EUROPE: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 470 TABLE 662 ASIA PACIFIC: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 470 TABLE 663 LATIN AMERICA: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 471 TABLE 664 MIDDLE EAST: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 471 TABLE 665 GCC COUNTRIES: PROTEOMICS MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 471 TABLE 666 PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY REGION, 2024–2031 (USD MILLION) 472 TABLE 667 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 473 TABLE 668 EUROPE: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 473 TABLE 669 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 474 TABLE 670 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 474 TABLE 671 MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 475 TABLE 672 GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL LABORATORIES, BY COUNTRY, 2024–2031 (USD MILLION) 475 TABLE 673 PROTEOMICS MARKET FOR OTHER END USERS, BY REGION, 2024–2031 (USD MILLION) 476 TABLE 674 NORTH AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 476 TABLE 675 EUROPE: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 477 TABLE 676 ASIA PACIFIC: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 477 TABLE 677 LATIN AMERICA: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 478 TABLE 678 MIDDLE EAST: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 478 TABLE 679 GCC COUNTRIES: PROTEOMICS MARKET FOR OTHER END USERS, BY COUNTRY, 2024–2031 (USD MILLION) 478 TABLE 680 PROTEOMICS MARKET, BY REGION, 2024–2031 (USD MILLION) 480 TABLE 681 NORTH AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 481 TABLE 682 NORTH AMERICA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 482 TABLE 683 ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 482 TABLE 684 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 685 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 483 TABLE 686 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 687 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 484 TABLE 688 NORTH AMERICA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 485 TABLE 689 NORTH AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 485 TABLE 690 NORTH AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 486 TABLE 691 NORTH AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 486 TABLE 692 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 486 TABLE 693 NORTH AMERICA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 694 NORTH AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 695 NORTH AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 487 TABLE 696 NORTH AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 697 NORTH AMERICA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 488 TABLE 698 NORTH AMERICA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 488 TABLE 699 NORTH AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 489 TABLE 700 NORTH AMERICA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 489 TABLE 701 NORTH AMERICA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 490 TABLE 702 NORTH AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 490 TABLE 703 NORTH AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 491 TABLE 704 NORTH AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 491 TABLE 705 NORTH AMERICA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 492 TABLE 706 US: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 493 TABLE 707 US: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 493 TABLE 708 US: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 709 US: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 710 US: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 494 TABLE 711 US: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 495 TABLE 712 US: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 495 TABLE 713 US: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 714 US: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 496 TABLE 715 US: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 716 US: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 717 US: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 497 TABLE 718 US: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 719 US: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 720 US: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 498 TABLE 721 US: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 499 TABLE 722 US: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 499 TABLE 723 US: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 500 TABLE 724 US: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 500 TABLE 725 US: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 501 TABLE 726 US: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 501 TABLE 727 US: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 728 US: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 502 TABLE 729 US: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 503 TABLE 730 CANADA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 504 TABLE 731 CANADA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 504 TABLE 732 CANADA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 505 TABLE 733 CANADA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 505 TABLE 734 CANADA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 735 CANADA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 506 TABLE 736 CANADA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 507 TABLE 737 CANADA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 507 TABLE 738 CANADA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 739 CANADA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 740 CANADA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 508 TABLE 741 CANADA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 742 CANADA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 743 CANADA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 509 TABLE 744 CANADA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 510 TABLE 745 CANADA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 510 TABLE 746 CANADA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 510 TABLE 747 CANADA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 511 TABLE 748 CANADA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 511 TABLE 749 CANADA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 512 TABLE 750 CANADA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 512 TABLE 751 CANADA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 752 CANADA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 513 TABLE 753 CANADA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 514 TABLE 754 EUROPE: PROTEOMICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 515 TABLE 755 EUROPE: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 515 TABLE 756 EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 516 TABLE 757 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 516 TABLE 758 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 759 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 760 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 517 TABLE 761 EUROPE: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 518 TABLE 762 EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 518 TABLE 763 EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 519 TABLE 764 EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 519 TABLE 765 EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 519 TABLE 766 EUROPE: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 520 TABLE 767 EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 520 TABLE 768 EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 520 TABLE 769 EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 521 TABLE 770 EUROPE: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 521 TABLE 771 EUROPE: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 521 TABLE 772 EUROPE: CORE PROTEOMICS SERVICES MARKET, BY TYPE , 2024–2031 (USD MILLION) 522 TABLE 773 EUROPE: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 522 TABLE 774 EUROPE: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 523 TABLE 775 EUROPE: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 523 TABLE 776 EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 524 TABLE 777 EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 524 TABLE 778 EUROPE: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 525 TABLE 779 GERMANY: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 526 TABLE 780 GERMANY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 526 TABLE 781 GERMANY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 527 TABLE 782 GERMANY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 527 TABLE 783 GERMANY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 528 TABLE 784 GERMANY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 528 TABLE 785 GERMANY: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 529 TABLE 786 GERMANY: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 529 TABLE 787 GERMANY: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 788 GERMANY: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 789 GERMANY: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 530 TABLE 790 GERMANY: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 791 GERMANY: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 792 GERMANY: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 531 TABLE 793 GERMANY: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 532 TABLE 794 GERMANY: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 532 TABLE 795 GERMANY: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 532 TABLE 796 GERMANY: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 533 TABLE 797 GERMANY: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 533 TABLE 798 GERMANY: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 534 TABLE 799 GERMANY: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 534 TABLE 800 GERMANY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 535 TABLE 801 GERMANY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 535 TABLE 802 GERMANY: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 536 TABLE 804 UK: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 537 TABLE 805 UK: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 537 TABLE 807 UK: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 808 UK: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 809 UK: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 538 TABLE 810 UK: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 539 TABLE 811 UK: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 539 TABLE 812 UK: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 540 TABLE 813 UK: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 540 TABLE 814 UK: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 541 TABLE 815 UK: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 541 TABLE 816 UK: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 541 TABLE 817 UK: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 818 UK: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 819 UK: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 542 TABLE 820 UK: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 543 TABLE 821 UK: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 543 TABLE 822 UK: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 544 TABLE 823 UK: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 544 TABLE 824 UK: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 545 TABLE 825 UK: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 545 TABLE 826 UK: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 827 UK: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 546 TABLE 828 UK: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 547 TABLE 829 FRANCE: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 548 TABLE 830 FRANCE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 548 TABLE 831 FRANCE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 832 FRANCE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 833 FRANCE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 549 TABLE 834 FRANCE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 550 TABLE 835 FRANCE: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 550 TABLE 836 FRANCE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 551 TABLE 837 FRANCE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 551 TABLE 838 FRANCE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 552 TABLE 839 FRANCE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 552 TABLE 840 FRANCE: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 552 TABLE 841 FRANCE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 553 TABLE 842 FRANCE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 553 TABLE 843 FRANCE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 553 TABLE 844 FRANCE: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 554 TABLE 845 FRANCE: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 554 TABLE 846 FRANCE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 555 TABLE 847 FRANCE: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 555 TABLE 848 FRANCE: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 556 TABLE 849 FRANCE: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 556 TABLE 850 FRANCE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 557 TABLE 851 FRANCE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 557 TABLE 852 FRANCE: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 558 TABLE 853 SWITZERLAND: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 559 TABLE 854 SWITZERLAND: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 559 TABLE 855 SWITZERLAND: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 560 TABLE 856 SWITZERLAND: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 560 TABLE 857 SWITZERLAND: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 561 TABLE 858 SWITZERLAND: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 561 TABLE 859 SWITZERLAND: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 562 TABLE 860 SWITZERLAND: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 562 TABLE 861 SWITZERLAND: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 563 TABLE 862 SWITZERLAND: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 563 TABLE 863 SWITZERLAND: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 563 TABLE 864 SWITZERLAND: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 564 TABLE 865 SWITZERLAND: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 564 TABLE 866 SWITZERLAND: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 564 TABLE 867 SWITZERLAND: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 565 TABLE 868 SWITZERLAND: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 565 TABLE 869 SWITZERLAND: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 565 TABLE 870 SWITZERLAND: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 566 TABLE 871 SWITZERLAND: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 566 TABLE 873 SWITZERLAND: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 567 TABLE 874 SWITZERLAND: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 567 TABLE 876 SWITZERLAND: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 568 TABLE 877 SWITZERLAND: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 568 TABLE 879 SWITZERLAND: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 569 TABLE 880 ITALY: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 570 TABLE 881 ITALY: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 570 TABLE 883 ITALY: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 571 TABLE 884 ITALY: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 571 TABLE 885 ITALY: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 571 TABLE 886 ITALY: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 572 TABLE 887 ITALY: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 572 TABLE 888 ITALY: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 573 TABLE 889 ITALY: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 573 TABLE 890 ITALY: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 574 TABLE 891 ITALY: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 574 TABLE 892 ITALY: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 574 TABLE 893 ITALY: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 575 TABLE 894 ITALY: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 575 TABLE 895 ITALY: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 575 TABLE 896 ITALY: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 576 TABLE 897 ITALY: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 576 TABLE 898 ITALY: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 577 TABLE 899 ITALY: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 577 TABLE 900 ITALY: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 578 TABLE 901 ITALY: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 578 TABLE 902 ITALY: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 579 TABLE 903 ITALY: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 579 TABLE 904 ITALY: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 580 TABLE 905 SPAIN: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 581 TABLE 906 SPAIN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 581 TABLE 907 SPAIN: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 582 TABLE 908 SPAIN: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 582 TABLE 909 SPAIN: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 583 TABLE 910 SPAIN: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 583 TABLE 911 SPAIN: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 584 TABLE 912 SPAIN: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 584 TABLE 913 SPAIN: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 585 TABLE 914 SPAIN: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 585 TABLE 915 SPAIN: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 585 TABLE 916 SPAIN: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 586 TABLE 917 SPAIN: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 586 TABLE 918 SPAIN: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 586 TABLE 919 SPAIN: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 587 TABLE 920 SPAIN: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 587 TABLE 921 SPAIN: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 587 TABLE 922 SPAIN: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 588 TABLE 923 SPAIN: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 588 TABLE 924 SPAIN: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 589 TABLE 925 SPAIN: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 589 TABLE 926 SPAIN: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 590 TABLE 927 SPAIN: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 590 TABLE 928 SPAIN: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 591 TABLE 930 REST OF EUROPE: PROTEOMICS MARKET, BY OFFERING , 2024–2031 (USD MILLION) 592 TABLE 931 REST OF EUROPE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 592 TABLE 932 REST OF EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 593 TABLE 933 REST OF EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 593 TABLE 934 REST OF EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 594 TABLE 935 REST OF EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 594 TABLE 936 REST OF EUROPE: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 595 TABLE 937 REST OF EUROPE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 595 TABLE 938 REST OF EUROPE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 596 TABLE 939 REST OF EUROPE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 596 TABLE 940 REST OF EUROPE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 596 TABLE 941 REST OF EUROPE: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 597 TABLE 942 REST OF EUROPE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 597 TABLE 943 REST OF EUROPE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 597 TABLE 944 REST OF EUROPE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 598 TABLE 945 REST OF EUROPE: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 598 TABLE 946 REST OF EUROPE: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 598 TABLE 947 REST OF EUROPE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 599 TABLE 948 REST OF EUROPE: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 599 TABLE 949 REST OF EUROPE: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 600 TABLE 950 REST OF EUROPE: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 600 TABLE 952 REST OF EUROPE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 601 TABLE 953 REST OF EUROPE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 601 TABLE 954 REST OF EUROPE: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 602 TABLE 955 ASIA PACIFIC: PROTEOMICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 603 TABLE 956 ASIA PACIFIC: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 604 TABLE 957 ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 604 TABLE 958 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 605 TABLE 959 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 605 TABLE 960 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 606 TABLE 961 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 606 TABLE 962 ASIA PACIFIC: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 607 TABLE 963 ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 607 TABLE 964 ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 608 TABLE 965 ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 608 TABLE 966 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 608 TABLE 967 ASIA PACIFIC: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 609 TABLE 968 ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 609 TABLE 969 ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 609 TABLE 970 ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 610 TABLE 971 ASIA PACIFIC: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 610 TABLE 972 ASIA PACIFIC: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 610 TABLE 973 ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 611 TABLE 974 ASIA PACIFIC: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 611 TABLE 975 ASIA PACIFIC: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 612 TABLE 976 ASIA PACIFIC: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 612 TABLE 977 ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 613 TABLE 978 ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 613 TABLE 979 ASIA PACIFIC: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 614 TABLE 980 CHINA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 615 TABLE 981 CHINA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 615 TABLE 982 CHINA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 616 TABLE 983 CHINA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 616 TABLE 984 CHINA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 616 TABLE 985 CHINA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 617 TABLE 986 CHINA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 617 TABLE 987 CHINA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 618 TABLE 988 CHINA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 618 TABLE 989 CHINA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 619 TABLE 990 CHINA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 619 TABLE 991 CHINA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 619 TABLE 992 CHINA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 620 TABLE 993 CHINA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 620 TABLE 994 CHINA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 620 TABLE 995 CHINA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 621 TABLE 996 CHINA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 621 TABLE 997 CHINA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 622 TABLE 998 CHINA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 622 TABLE 999 CHINA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 623 TABLE 1000 CHINA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 623 TABLE 1001 CHINA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 624 TABLE 1002 CHINA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 624 TABLE 1003 CHINA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 625 TABLE 1004 JAPAN: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 626 TABLE 1005 JAPAN: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 626 TABLE 1006 JAPAN: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 627 TABLE 1007 JAPAN: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 627 TABLE 1008 JAPAN: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 628 TABLE 1009 JAPAN: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 628 TABLE 1010 JAPAN: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 629 TABLE 1011 JAPAN: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 629 TABLE 1012 JAPAN: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 630 TABLE 1013 JAPAN: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 630 TABLE 1014 JAPAN: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 630 TABLE 1015 JAPAN: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 631 TABLE 1016 JAPAN: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 631 TABLE 1017 JAPAN: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 631 TABLE 1018 JAPAN: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 632 TABLE 1019 JAPAN: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 632 TABLE 1020 JAPAN: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 632 TABLE 1021 JAPAN: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 633 TABLE 1022 JAPAN: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 633 TABLE 1023 JAPAN: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 634 TABLE 1024 JAPAN: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 634 TABLE 1025 JAPAN: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 635 TABLE 1026 JAPAN: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 635 TABLE 1027 JAPAN: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 636 TABLE 1028 INDIA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 637 TABLE 1029 INDIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 637 TABLE 1030 INDIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 638 TABLE 1031 INDIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 638 TABLE 1032 INDIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 639 TABLE 1033 INDIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 639 TABLE 1034 INDIA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 640 TABLE 1035 INDIA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 640 TABLE 1036 INDIA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 641 TABLE 1037 INDIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 641 TABLE 1038 INDIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 641 TABLE 1039 INDIA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 642 TABLE 1040 INDIA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 642 TABLE 1041 INDIA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 642 TABLE 1042 INDIA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 643 TABLE 1043 INDIA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 643 TABLE 1044 INDIA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 643 TABLE 1045 INDIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 644 TABLE 1046 INDIA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 644 TABLE 1047 INDIA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 645 TABLE 1048 INDIA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 645 TABLE 1049 INDIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 646 TABLE 1050 INDIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 646 TABLE 1051 INDIA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 647 TABLE 1052 SOUTH KOREA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 648 TABLE 1053 SOUTH KOREA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 648 TABLE 1054 SOUTH KOREA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 649 TABLE 1055 SOUTH KOREA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 649 TABLE 1056 SOUTH KOREA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 650 TABLE 1057 SOUTH KOREA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 650 TABLE 1058 SOUTH KOREA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 651 TABLE 1059 SOUTH KOREA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 651 TABLE 1060 SOUTH KOREA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 652 TABLE 1061 SOUTH KOREA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 652 TABLE 1062 SOUTH KOREA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 652 TABLE 1063 SOUTH KOREA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 653 TABLE 1064 SOUTH KOREA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 653 TABLE 1065 SOUTH KOREA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 653 TABLE 1066 SOUTH KOREA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 654 TABLE 1067 SOUTH KOREA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 654 TABLE 1068 SOUTH KOREA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 654 TABLE 1069 SOUTH KOREA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 655 TABLE 1070 SOUTH KOREA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 655 TABLE 1071 SOUTH KOREA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 656 TABLE 1072 SOUTH KOREA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 656 TABLE 1073 SOUTH KOREA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 657 TABLE 1074 SOUTH KOREA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 657 TABLE 1075 SOUTH KOREA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 658 TABLE 1076 AUSTRALIA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 659 TABLE 1077 AUSTRALIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 659 TABLE 1078 AUSTRALIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 660 TABLE 1079 AUSTRALIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 660 TABLE 1080 AUSTRALIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 661 TABLE 1081 AUSTRALIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 661 TABLE 1082 AUSTRALIA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 662 TABLE 1083 AUSTRALIA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 662 TABLE 1084 AUSTRALIA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 663 TABLE 1085 AUSTRALIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 663 TABLE 1086 AUSTRALIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 663 TABLE 1087 AUSTRALIA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 664 TABLE 1088 AUSTRALIA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 664 TABLE 1089 AUSTRALIA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 664 TABLE 1090 AUSTRALIA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 665 TABLE 1091 AUSTRALIA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 665 TABLE 1092 AUSTRALIA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 665 TABLE 1093 AUSTRALIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 666 TABLE 1094 AUSTRALIA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 666 TABLE 1095 AUSTRALIA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 667 TABLE 1096 AUSTRALIA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 667 TABLE 1097 AUSTRALIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 668 TABLE 1098 AUSTRALIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 668 TABLE 1099 AUSTRALIA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 669 TABLE 1100 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 669 TABLE 1101 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 670 TABLE 1102 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 670 TABLE 1103 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 671 TABLE 1104 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 671 TABLE 1105 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 671 TABLE 1106 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 672 TABLE 1107 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 672 TABLE 1108 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 673 TABLE 1109 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 673 TABLE 1110 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 673 TABLE 1111 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 674 TABLE 1112 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 674 TABLE 1113 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 674 TABLE 1114 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 675 TABLE 1115 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 675 TABLE 1116 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 675 TABLE 1117 REST OF ASIA PACIFIC: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 676 TABLE 1118 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 676 TABLE 1119 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 677 TABLE 1120 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 677 TABLE 1121 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 678 TABLE 1122 REST OF ASIA PACIFIC: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 678 TABLE 1123 REST OF ASIA PACIFIC: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 679 TABLE 1124 LATIN AMERICA: PROTEOMICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 679 TABLE 1125 LATIN AMERICA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 680 TABLE 1126 LATIN AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 680 TABLE 1127 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 681 TABLE 1128 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 681 TABLE 1129 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 682 TABLE 1130 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 682 TABLE 1131 LATIN AMERICA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 683 TABLE 1132 LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 683 TABLE 1133 LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 684 TABLE 1134 LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 684 TABLE 1135 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 684 TABLE 1136 LATIN AMERICA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 685 TABLE 1137 LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 685 TABLE 1138 LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 685 TABLE 1139 LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 686 TABLE 1140 LATIN AMERICA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 686 TABLE 1141 LATIN AMERICA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 686 TABLE 1142 LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 687 TABLE 1143 LATIN AMERICA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 687 TABLE 1144 LATIN AMERICA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 688 TABLE 1145 LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 688 TABLE 1146 LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 689 TABLE 1147 LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 689 TABLE 1148 LATIN AMERICA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 690 TABLE 1149 BRAZIL: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 691 TABLE 1150 BRAZIL: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 691 TABLE 1151 BRAZIL: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 692 TABLE 1152 BRAZIL: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 692 TABLE 1153 BRAZIL: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 692 TABLE 1154 BRAZIL: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 693 TABLE 1155 BRAZIL: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 693 TABLE 1156 BRAZIL: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 694 TABLE 1157 BRAZIL: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 694 TABLE 1158 BRAZIL: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 695 TABLE 1159 BRAZIL: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 695 TABLE 1160 BRAZIL: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 695 TABLE 1161 BRAZIL: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 696 TABLE 1162 BRAZIL: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 696 TABLE 1163 BRAZIL: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 696 TABLE 1164 BRAZIL: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 697 TABLE 1165 BRAZIL: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 697 TABLE 1166 BRAZIL: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 698 TABLE 1167 BRAZIL: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 698 TABLE 1168 BRAZIL: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 699 TABLE 1169 BRAZIL: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 699 TABLE 1170 BRAZIL: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 700 TABLE 1171 BRAZIL: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 700 TABLE 1172 BRAZIL: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 701 TABLE 1173 MEXICO: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 702 TABLE 1174 MEXICO: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 702 TABLE 1175 MEXICO: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 703 TABLE 1176 MEXICO: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 703 TABLE 1177 MEXICO: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 704 TABLE 1178 MEXICO: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 704 TABLE 1179 MEXICO: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 705 TABLE 1180 MEXICO: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 705 TABLE 1181 MEXICO: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 706 TABLE 1182 MEXICO: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 706 TABLE 1183 MEXICO: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 706 TABLE 1184 MEXICO: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 707 TABLE 1185 MEXICO: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 707 TABLE 1186 MEXICO: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 707 TABLE 1187 MEXICO: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 708 TABLE 1188 MEXICO: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 708 TABLE 1189 MEXICO: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 708 TABLE 1190 MEXICO: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 709 TABLE 1191 MEXICO: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 709 TABLE 1192 MEXICO: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 710 TABLE 1193 MEXICO: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 710 TABLE 1194 MEXICO: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 711 TABLE 1195 MEXICO: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 711 TABLE 1196 MEXICO: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 712 TABLE 1197 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 713 TABLE 1198 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 713 TABLE 1199 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 714 TABLE 1200 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 714 TABLE 1201 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 715 TABLE 1202 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 715 TABLE 1203 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 716 TABLE 1204 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 716 TABLE 1205 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 717 TABLE 1206 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 717 TABLE 1207 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 717 TABLE 1208 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 718 TABLE 1209 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 718 TABLE 1210 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 718 TABLE 1211 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 719 TABLE 1212 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 719 TABLE 1213 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 719 TABLE 1214 REST OF LATIN AMERICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 720 TABLE 1215 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 720 TABLE 1216 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 721 TABLE 1217 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 721 TABLE 1218 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 722 TABLE 1219 REST OF LATIN AMERICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 722 TABLE 1220 REST OF LATIN AMERICA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 723 TABLE 1221 MIDDLE EAST: PROTEOMICS MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 723 TABLE 1222 MIDDLE EAST: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 724 TABLE 1223 MIDDLE EAST: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 724 TABLE 1224 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 725 TABLE 1225 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 725 TABLE 1226 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 726 TABLE 1227 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 726 TABLE 1228 MIDDLE EAST: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 727 TABLE 1229 MIDDLE EAST: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 727 TABLE 1230 MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 728 TABLE 1231 MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 728 TABLE 1232 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 728 TABLE 1233 MIDDLE EAST: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 729 TABLE 1234 MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 729 TABLE 1235 MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 729 TABLE 1236 MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 730 TABLE 1237 MIDDLE EAST: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 730 TABLE 1238 MIDDLE EAST: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 730 TABLE 1239 MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 731 TABLE 1240 MIDDLE EAST: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 731 TABLE 1241 MIDDLE EAST: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 732 TABLE 1242 MIDDLE EAST: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 732 TABLE 1243 MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 733 TABLE 1244 MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 733 TABLE 1245 MIDDLE EAST: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 734 TABLE 1246 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY COUNTRY, 2024–2031 (USD MILLION) 734 TABLE 1247 GCC COUNTRIES: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 735 TABLE 1248 GCC COUNTRIES: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 735 TABLE 1249 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 736 TABLE 1250 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 736 TABLE 1251 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 737 TABLE 1252 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 737 TABLE 1253 GCC COUNTRIES: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 738 TABLE 1254 GCC COUNTRIES: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 738 TABLE 1255 GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 739 TABLE 1256 GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 739 TABLE 1257 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 739 TABLE 1258 GCC COUNTRIES: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 740 TABLE 1259 GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 740 TABLE 1260 GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 740 TABLE 1261 GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 741 TABLE 1262 GCC COUNTRIES: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 741 TABLE 1263 GCC COUNTRIES: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 741 TABLE 1264 GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 742 TABLE 1265 GCC COUNTRIES: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 742 TABLE 1266 GCC COUNTRIES: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 743 TABLE 1267 GCC COUNTRIES: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 743 TABLE 1268 GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 744 TABLE 1269 GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 744 TABLE 1270 GCC COUNTRIES: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 745 TABLE 1271 SAUDI ARABIA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 746 TABLE 1272 SAUDI ARABIA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 746 TABLE 1273 SAUDI ARABIA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 747 TABLE 1274 SAUDI ARABIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 747 TABLE 1275 SAUDI ARABIA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 748 TABLE 1276 SAUDI ARABIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 748 TABLE 1277 SAUDI ARABIA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 749 TABLE 1278 SAUDI ARABIA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 749 TABLE 1279 SAUDI ARABIA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 750 TABLE 1280 SAUDI ARABIA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 750 TABLE 1281 SAUDI ARABIA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 750 TABLE 1282 SAUDI ARABIA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 751 TABLE 1283 SAUDI ARABIA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 751 TABLE 1284 SAUDI ARABIA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 751 TABLE 1285 SAUDI ARABIA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 752 TABLE 1286 SAUDI ARABIA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 752 TABLE 1287 SAUDI ARABIA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 752 TABLE 1288 SAUDI ARABIA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 753 TABLE 1289 SAUDI ARABIA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 753 TABLE 1290 SAUDI ARABIA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 754 TABLE 1291 SAUDI ARABIA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 754 TABLE 1292 SAUDI ARABIA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 755 TABLE 1293 SAUDI ARABIA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 755 TABLE 1294 SAUDI ARABIA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 756 TABLE 1295 UAE: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 757 TABLE 1296 UAE: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 757 TABLE 1297 UAE: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 758 TABLE 1298 UAE: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 758 TABLE 1299 UAE: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 758 TABLE 1300 UAE: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 759 TABLE 1301 UAE: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 759 TABLE 1302 UAE: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 760 TABLE 1303 UAE: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 760 TABLE 1304 UAE: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 761 TABLE 1305 UAE: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 761 TABLE 1306 UAE: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 761 TABLE 1307 UAE: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 762 TABLE 1308 UAE: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 762 TABLE 1309 UAE: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 762 TABLE 1310 UAE: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 763 TABLE 1311 UAE: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 763 TABLE 1312 UAE: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 764 TABLE 1313 UAE: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 764 TABLE 1314 UAE: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 765 TABLE 1315 UAE: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 765 TABLE 1316 UAE: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 766 TABLE 1317 UAE: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 766 TABLE 1318 UAE: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 767 TABLE 1319 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 768 TABLE 1320 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 768 TABLE 1321 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 769 TABLE 1322 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 769 TABLE 1323 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 770 TABLE 1324 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 770 TABLE 1325 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 771 TABLE 1326 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 771 TABLE 1327 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 772 TABLE 1328 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 772 TABLE 1329 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 772 TABLE 1330 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 773 TABLE 1331 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 773 TABLE 1332 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 773 TABLE 1333 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 774 TABLE 1334 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY TYPE , 2024–2031 (USD MILLION) 774 TABLE 1335 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 774 TABLE 1336 REST OF GCC COUNTRIES: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 775 TABLE 1337 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 775 TABLE 1338 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 776 TABLE 1339 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 776 TABLE 1340 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 777 TABLE 1341 REST OF GCC COUNTRIES: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 777 TABLE 1342 REST OF GCC COUNTRIES: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 778 TABLE 1343 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 779 TABLE 1344 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 779 TABLE 1345 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 780 TABLE 1346 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 780 TABLE 1347 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 781 TABLE 1348 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 781 TABLE 1349 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 782 TABLE 1350 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 782 TABLE 1351 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 783 TABLE 1352 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 783 TABLE 1353 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 783 TABLE 1354 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 784 TABLE 1355 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 784 TABLE 1356 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 784 TABLE 1357 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 785 TABLE 1358 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 785 TABLE 1359 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 785 TABLE 1360 REST OF MIDDLE EAST: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 786 TABLE 1361 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 786 TABLE 1362 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 787 TABLE 1363 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 787 TABLE 1364 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 788 TABLE 1365 REST OF MIDDLE EAST: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 788 TABLE 1366 REST OF MIDDLE EAST: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 789 TABLE 1367 AFRICA: PROTEOMICS MARKET, BY OFFERING, 2024–2031 (USD MILLION) 790 TABLE 1368 AFRICA: PROTEOMICS MARKET, BY INSTRUMENTATION TECHNOLOGY, 2024–2031 (USD MILLION) 790 TABLE 1369 AFRICA: PROTEOMICS MARKET FOR SPECTROSCOPY, BY TYPE, 2024–2031 (USD MILLION) 791 TABLE 1370 AFRICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY, BY TYPE, 2024–2031 (USD MILLION) 791 TABLE 1371 AFRICA: PROTEOMICS MARKET FOR ELECTROPHORESIS, BY TYPE, 2024–2031 (USD MILLION) 792 TABLE 1372 AFRICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAYS, BY TYPE, 2024–2031 (USD MILLION) 792 TABLE 1373 AFRICA: PROTEOMICS MARKET, BY REAGENTS & CONSUMABLES, 2024–2031 (USD MILLION) 793 TABLE 1374 AFRICA: PROTEOMICS MARKET FOR IMMUNOASSAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 793 TABLE 1375 AFRICA: PROTEOMICS MARKET FOR SPECTROSCOPY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 794 TABLE 1376 AFRICA: PROTEOMICS MARKET FOR CHROMATOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 794 TABLE 1377 AFRICA: PROTEOMICS MARKET FOR PROTEIN MICROARRAY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 794 TABLE 1378 AFRICA: PROTEOMICS MARKET FOR BIOCHIPS, BY TYPE, 2024–2031 (USD MILLION) 795 TABLE 1379 AFRICA: PROTEOMICS MARKET FOR X-RAY CRYSTALLOGRAPHY REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 795 TABLE 1380 AFRICA: PROTEOMICS MARKET FOR ELECTROPHORESIS REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 795 TABLE 1381 AFRICA: PROTEOMICS MARKET FOR PROTEIN FRACTIONATION REAGENTS & CONSUMABLES, BY TYPE, 2024–2031 (USD MILLION) 796 TABLE 1382 AFRICA: PROTEOMICS MARKET, BY TYPE, 2024–2031 (USD MILLION) 796 TABLE 1383 AFRICA: PROTEOMICS MARKET, BY SERVICE, 2024–2031 (USD MILLION) 796 TABLE 1384 AFRICA: CORE PROTEOMICS SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 797 TABLE 1385 AFRICA: PROTEOMICS MARKET, BY SOFTWARE, 2024–2031 (USD MILLION) 797 TABLE 1386 AFRICA: PROTEOMICS MARKET, BY WORKFLOW, 2024–2031 (USD MILLION) 798 TABLE 1387 AFRICA: PROTEOMICS MARKET, BY APPLICATION, 2024–2031 (USD MILLION) 798 TABLE 1388 AFRICA: PROTEOMICS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2024–2031 (USD MILLION) 799 TABLE 1389 AFRICA: PROTEOMICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY TYPE, 2024–2031 (USD MILLION) 799 TABLE 1390 AFRICA: PROTEOMICS MARKET, BY END USER, 2024–2031 (USD MILLION) 800 TABLE 1391 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS IN PROTEOMICS MARKET, JANUARY 2023-APRIL 2026 801 TABLE 1392 PROTEOMICS MARKET: DEGREE OF COMPETITION 805 TABLE 1393 PROTEOMICS MARKET: REGION FOOTPRINT 811 TABLE 1394 PROTEOMICS MARKET: INSTRUMENTATION TECHNOLOGY FOOTPRINT 812 TABLE 1395 PROTEOMICS MARKET: REAGENT FOOTPRINT 813 TABLE 1396 PROTEOMICS MARKET: SERVICE FOOTPRINT 815 TABLE 1397 PROTEOMICS MARKET: SOFTWARE FOOTPRINT 816 TABLE 1398 PROTEOMICS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS 819 TABLE 1399 PROTEOMICS MARKET: COMPETITIVE BENCHMARKING OF STARTUPS/SMES 820 TABLE 1400 PROTEOMICS MARKET: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 822 TABLE 1401 PROTEOMICS MARKET: DEALS, JANUARY 2023–APRIL 2026 823 TABLE 1402 PROTEOMICS MARKET: EXPANSIONS, JANUARY 2023–APRIL 2026 824 TABLE 1403 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW 825 TABLE 1404 THERMO FISHER SCIENTIFIC INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 826 TABLE 1405 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 839 TABLE 1406 THERMO FISHER SCIENTIFIC INC.: DEALS, JANUARY 2023–APRIL 2026 840 TABLE 1407 AGILENT TECHNOLOGIES, INC.: COMPANY OVERVIEW 841 TABLE 1408 AGILENT TECHNOLOGIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 842 TABLE 1409 AGILENT TECHNOLOGIES, INC.: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 847 TABLE 1410 AGILENT TECHNOLOGIES, INC.: DEALS, JANUARY 2023–APRIL 2026 848 TABLE 1411 AGILENT TECHNOLOGIES, INC.: EXPANSIONS, JANUARY 2023-APRIL 2026 849 TABLE 1412 MERCK KGAA: COMPANY OVERVIEW 850 TABLE 1413 MERCK KGAA: PRODUCTS/SERVICES/SOLUTIONS OFFERED 851 TABLE 1414 MERCK KGAA: DEALS, JANUARY 2023-APRIL 2026 854 TABLE 1415 DANAHER CORPORATION: COMPANY OVERVIEW 855 TABLE 1416 DANAHER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 856 TABLE 1417 DANAHER CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 868 TABLE 1418 DANAHER CORPORATION: DEALS, JANUARY 2023–APRIL 2026 869 TABLE 1419 SHIMADZU CORPORATION: COMPANY OVERVIEW 870 TABLE 1420 SHIMADZU CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 871 TABLE 1421 SHIMADZU CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 876 TABLE 1422 SHIMADZU CORPORATION: EXPANSIONS, JANUARY 2023–APRIL 2026 876 TABLE 1423 WATERS CORPORATION: COMPANY OVERVIEW 878 TABLE 1424 WATERS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 879 TABLE 1425 WATERS CORPORATION: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 886 TABLE 1426 WATERS CORPORATION: DEALS, JANUARY 2023–APRIL 2026 886 TABLE 1427 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW 887 TABLE 1428 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 888 TABLE 1429 BRUKER: COMPANY OVERVIEW 897 TABLE 1430 BRUKER: PRODUCTS/SERVICES/SOLUTIONS OFFERED 898 TABLE 1431 BRUKER: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 904 TABLE 1432 BRUKER: DEALS, JANUARY 2023–APRIL 2026 905 TABLE 1433 REVVITY: COMPANY OVERVIEW 906 TABLE 1434 REVVITY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 907 TABLE 1435 REVVITY: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 910 TABLE 1436 ILLUMINA, INC.: COMPANY OVERVIEW 911 TABLE 1437 ILLUMINA, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 912 TABLE 1438 ILLUMINA, INC.: DEALS, JANUARY 2023–APRIL 2026 914 TABLE 1439 PROMEGA CORPORATION: COMPANY OVERVIEW 915 TABLE 1440 PROMEGA CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 915 TABLE 1441 EUROFINS SCIENTIFIC: COMPANY OVERVIEW 919 TABLE 1442 EUROFINS SCIENTIFIC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 920 TABLE 1443 EUROFINS SCIENTIFIC: DEALS, JANUARY 2023–APRIL 2026 921 TABLE 1444 QIAGEN: COMPANY OVERVIEW 922 TABLE 1445 QIAGEN: PRODUCTS/SERVICES/SOLUTIONS OFFERED 923 TABLE 1446 QIAGEN: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 926 TABLE 1447 QIAGEN: DEALS, JANUARY 2023–APRIL 2026 927 TABLE 1448 CHARLES RIVER LABORATORIES: COMPANY OVERVIEW 928 TABLE 1449 CHARLES RIVER LABORATORIES: PRODUCTS/SERVICES/SOLUTIONS OFFERED 929 TABLE 1450 CHARLES RIVER LABORATORIES: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 931 TABLE 1451 CHARLES RIVER LABORATORIES: DEALS, JANUARY 2023–APRIL 2026 932 TABLE 1452 PROTAGENE: COMPANY OVERVIEW 933 TABLE 1453 PROTAGENE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 933 TABLE 1454 BIO-TECHNE: COMPANY OVERVIEW 936 TABLE 1455 BIO-TECHNE: PRODUCTS/SERVICES/SOLUTIONS OFFERED 937 TABLE 1456 AZENTA US INC.: COMPANY OVERVIEW 939 TABLE 1457 AZENTA US INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 940 TABLE 1458 QUANTERIX: COMPANY OVERVIEW 941 TABLE 1459 QUANTERIX: PRODUCTS/SERVICES/SOLUTIONS OFFERED 942 TABLE 1460 PROTEOMICS INTERNATIONAL: COMPANY OVERVIEW 943 TABLE 1461 PROTEOMICS INTERNATIONAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 944 TABLE 1462 HAMILTON COMPANY: COMPANY OVERVIEW 945 TABLE 1463 HAMILTON COMPANY: PRODUCTS/SERVICES/SOLUTIONS OFFERED 945 TABLE 1464 HAMILTON COMPANY: PRODUCT LAUNCHES, JANUARY 2023–APRIL 2026 946 TABLE 1465 CREATIVE PROTEOMICS: COMPANY OVERVIEW 947 TABLE 1466 HORIBA, LTD.: COMPANY OVERVIEW 949 TABLE 1467 LABVANTAGE-BIOMAX GMBH: COMPANY OVERVIEW 950 TABLE 1468 FIOS GENOMICS: COMPANY OVERVIEW 951 TABLE 1469 MEDGENOME: COMPANY OVERVIEW 952 TABLE 1470 BIOGNOSYS AG: COMPANY OVERVIEW 953 TABLE 1471 MACROGEN, INC.: COMPANY OVERVIEW 954 TABLE 1472 CELL SIGNALING TECHNOLOGY, INC.: COMPANY OVERVIEW 955 TABLE 1473 STANDARD BIOTOOLS: COMPANY OVERVIEW 956 TABLE 1474 PIXELGEN TECHNOLOGIES: COMPANY OVERVIEW 957 TABLE 1475 APPLIED BIOMICS: COMPANY OVERVIEW 957 TABLE 1476 QUANTUM-SI INCORPORATED: COMPANY OVERVIEW 958 TABLE 1477 ERISYON INC.: COMPANY OVERVIEW 959 TABLE 1478 NAUTILUS BIOTECHNOLOGY, INC.: COMPANY OVERVIEW 960 TABLE 1479 IMPACT ANALYSIS OF SUPPLY-SIDE AND DEMAND-SIDE FACTORS 972 TABLE 1480 RISK ASSESSMENT 973 FIGURE 1 PROTEOMICS MARKET SEGMENTATION AND REGIONS CONSIDERED 79 FIGURE 2 PROTEOMICS MARKET: YEARS CONSIDERED 81 FIGURE 3 MARKET SCENARIO 83 FIGURE 4 GLOBAL PROTEOMICS MARKET, 2024–2031 84 FIGURE 5 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN PROTEOMICS MARKET, 2023–2026 84 FIGURE 6 DISRUPTIONS INFLUENCING GROWTH OF PROTEOMICS MARKET 85 FIGURE 7 HIGH-GROWTH SEGMENTS IN PROTEOMICS MARKET, 2026–2031 86 FIGURE 8 ASIA PACIFIC TO REGISTER HIGHEST CAGR IN PROTEOMICS MARKET, IN TERMS OF VALUE, DURING FORECAST PERIOD 87 FIGURE 9 ADVANCEMENTS HIGH-THROUGHPUT MASS SPECTROMETRY TO DRIVE MARKET GROWTH 88 FIGURE 10 CORE PROTEOMICS SERVICES ACCOUNTED FOR LARGEST SHARE OF PROTEOMICS MARKET IN NORTH AMERICA IN 2025 89 FIGURE 11 ASIA PACIFIC IS LIKELY TO BE FASTEST-GROWING MARKET DURING FORECAST PERIOD 89 FIGURE 12 CLINICAL DIAGNOSTICS TO DOMINATE MARKET DURING FORECAST PERIOD 90 FIGURE 13 PROTEOMICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 92 FIGURE 14 PROTEOMICS MARKET: PORTER’S FIVE FORCES ANALYSIS 100 FIGURE 15 VALUE CHAIN ANALYSIS 104 FIGURE 16 PROTEOMICS MARKET: ECOSYSTEM ANALYSIS 106 FIGURE 17 AVERAGE SELLING PRICE OF INSTRUMENTATION, BY KEY PLAYER, 2025 (USD) 108 FIGURE 18 AVERAGE SELLING PRICE OF REAGENTS, BY KEY PLAYER, 2025 (USD) 109 FIGURE 19 AVERAGE SELLING PRICE OF INSTRUMENTATION, BY REGION, 2025 (USD) 110 FIGURE 20 AVERAGE SELLING PRICE OF REAGENTS, BY REGION, 2025 (USD) 110 FIGURE 21 PROTEOMICS MARKET: TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 115 FIGURE 22 INVESTMENT AND FUNDING SCENARIO, 2023–2025 (USD MILLION) 116 FIGURE 23 PATENT APPLICATIONS IN PROTEOMICS MARKET, JANUARY 2015- DECEMBER 2025 134 FIGURE 24 IMPACT OF AI/GEN AI ON THE PROTEOMICS MARKET 136 FIGURE 25 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS, BY OFFERING 140 FIGURE 26 KEY BUYING CRITERIA, BY END USER 141 FIGURE 27 NORTH AMERICA: PROTEOMICS MARKET SNAPSHOT 481 FIGURE 28 ASIA PACIFIC: PROTEOMICS MARKET SNAPSHOT 603 FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS IN PROTEOMICS MARKET, 2021–2025 (USD MILLION) 803 FIGURE 30 MARKET SHARE ANALYSIS, 2025 804 FIGURE 31 PROTEOMICS MARKET: BRAND COMPARATIVE ANALYSIS 807 FIGURE 32 PROTEOMICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 809 FIGURE 33 PROTEOMICS MARKET: COMPANY FOOTPRINT 810 FIGURE 34 PROTEOMICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 818 FIGURE 35 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS 821 FIGURE 36 EV/EBITDA OF KEY VENDORS 822 FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2025) 826 FIGURE 38 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2025) 842 FIGURE 39 MERCK KGAA: COMPANY SNAPSHOT (2025) 851 FIGURE 40 DANAHER CORPORATION: COMPANY SNAPSHOT (2025) 856 FIGURE 41 SHIMADZU CORPORATION: COMPANY SNAPSHOT (2024) 871 FIGURE 42 WATERS CORPORATION: COMPANY SNAPSHOT (2025) 879 FIGURE 43 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2025) 888 FIGURE 44 BRUKER: COMPANY SNAPSHOT (2025) 898 FIGURE 45 REVVITY: COMPANY SNAPSHOT (2025) 907 FIGURE 46 ILLUMINA, INC.: COMPANY SNAPSHOT (2025) 912 FIGURE 47 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2025) 920 FIGURE 48 QIAGEN: COMPANY SNAPSHOT (2025) 923 FIGURE 49 CHARLES RIVER LABORATORIES: COMPANY SNAPSHOT (2025) 929 FIGURE 50 BIO-TECHNE: COMPANY SNAPSHOT (2025) 937 FIGURE 51 AZENTA US INC.: COMPANY SNAPSHOT (2025) 940 FIGURE 52 QUANTERIX: COMPANY SNAPSHOT (2025) 941 FIGURE 53 PROTEOMICS INTERNATIONAL: COMPANY SNAPSHOT (2025) 943 FIGURE 54 PROTEOMICS MARKET: RESEARCH DESIGN 961 FIGURE 55 PROTEOMICS MARKET: BREAKDOWN OF PRIMARIES 963 FIGURE 56 PROTEOMICS MARKET: INSIGHTS FROM PRIMARIES 964 FIGURE 57 GLOBAL PROTEOMICS MARKET ESTIMATION, 2025 965 FIGURE 58 PROTEOMICS MARKET: COMPANY REVENUE ANALYSIS-BASED ESTIMATION (BOTTOM-UP APPROACH) (2025) 966 FIGURE 59 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE ANALYSIS (2025) 966 FIGURE 60 SEGMENTAL MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 967 FIGURE 61 PROTEOMICS MARKET: CAGR PROJECTIONS 970 FIGURE 62 PROTEOMICS MARKET: DATA TRIANGULATION 971

同分類最新報告（醫療與生命科學）

查看醫療與生命科學全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們